1. Intraoperative near-infrared fluorescence imaging targeting folate receptors identifies lung cancer in a large-animal model. Keating JJ, Runge JJ, Singhal S, Nims S, Venegas O, Durham AC, Swain G, Nie S, Low PS, Holt DE. Cancer. 123(6):1051-1060 (2017)
  2. Healing efficacy of fracture-targeted GSK3β inhibitor-loaded micelles for improved fracture repair. Low SA, Galliford CV, Jones-Hall YL, Roy J, Yang J, Low PS, Kopeček J. Nanomedicine (Lond). 12(3):185-193 (2017).
  3. Intraoperative molecular imaging to identify lung adenocarcinomas. Newton AD, Kennedy GT, Predina JD, Low PS, Singhal S. J Thorac Dis. 8(Suppl 9):S697-S704 (2016).
  4. Separation and dual detection of prostate cancer cells and protein biomarkers using a microchip device. Huang W, Chang CL, Brault ND, Gur O, Wang Z, Jalal SI, Low PS, Ratliff TL, Pili R, Savran CA. Lab Chip. 17(3):415-428 (2017).
  5. Folate-hapten mediated immunotherapy synergizes with vascular endothelial growth factor receptor inhibitors in treating murine models of cancer. Bandara NA, Bates CD, Lu Y, Hoylman EK, Low PS. Mol Cancer Ther. 16(3):461-468 (2017)
  6. Evaluation of nonpeptidic ligand conjugates for treatment of hypoxic and carbonic anhydrase IX-expressing cancers. Lv PC, Roy J, Putt KS, Low PS. Mol Cancer Ther. 16(3):453-460 (2017)
  7. Novel Use of Folate-Targeted Intraoperative Fluorescence, OTL38, in Robot-Assisted Laparoscopic Partial Nephrectomy: Report of the First Three Cases. Shum SC, Bahler CD, Low PS, Ratliff TL, Kheyfets SV, Natarajan JP, Sandusky GE, Sundaram CP. J Endourol Case Rep. 2(1):189-197 (2016).
  8. Global transformation of membrane properties via engagement of an SH2-like sequence in band 3. Puchulu-Campanella E, Turrini F, Li YH, Low PS. Proc Natl Acad Sci. 113(48):13732-13737 (2016).
  9. Inhibition of an erythrocyte tyrosine kinase with imatinib prevents Plasmodium falciparum egress and terminates parasitemia. Kesely KR, Panataleo A, Turrini FM, Olupot-Olupot P, Low PS. PLoS One. 11(10):e0164895 (2016).
  10. Reversible binding of deoxyhemoglobin to band 3 constitutes the molecular switch that mediates O2 regulation of erythrocyte properties. Chu H, McKenna MM, Krump NA, Zheng S, Mendelsohn L, Thein SL, Garrett LJ, Bodine DM, Low PS. Blood. 128(23):2708-2716 (2016).
  11. Single molecule studies of the diffusion of band 3 in erythrocytes with hemoglobin pathologies. Spector J, Kodippili GC, Ritchie K, Low PS. PLoS One. 11(9):e0162514 (2016).
  12. Diffusion of glycophorin A in human erythrocytes. Giger K, Habib I, Ritchie K, Low PS. BBA-Biomembranes. 1858(11):2839-2845 (2016).
  13. Design, synthesis and evaluation of a neurokinin 1 receptor-targeted near IR dye for fluorescence guided surgery of neuroendocrine cancers. Kanduluru AK, Srinivasarao M, Low PS. Bioconjug Chem. 27(9):2157-65 (2016).
  14. Identification of adducin-binding residues on the cytoplasmic domain of erythrocyte membrane protein, band 3. Franco T, Chu H, Low PS. Biochem J. 473(19):3147-58 (2016).
  15. Evaluation of nonpeptidic ligand conjugates for SPECT imaging of hypoxic and carbonic anhydrase IX-expressing cancers. Lv PC, Putt KS, Low PS. Bioconjug Chem. 27(7):1762-9 (2016).
  16. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17. Tummers QR, Hoogstins CE, Gaarenstroom KN, de Kroon CD, van Poelgeest MI, Vuyk J, Bosse T, Smit VT, van de Velde CJ, Cohen AF, Low PS, Burggraaf J, Vahrmeijer AL. Oncotarget. 7(22):32144-55 (2016).
  17. A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer. Hoogstins CE, Tummers QR, Gaarenstroom KN, de Kroon CD, Trimbos JB, Bosse T, Smit VT, Vuyk J, van de Velde CJ, Cohen AF, Low PS, Burggraaf J, Vahrmeijer AL. Clin Cancer Res. 15;22(12):2929-38 (2016).
  18. Optimization of folate-targeted immunotherapy for the treatment of experimental arthritis. Varghese B, Paulos C, Low PS. Inflammation. 39(4):1345-53 (2016).
  19. Direct In Vivo Evidence of Activated Macrophages in Human Osteoarthritis. Kraus VB, McDaniel G, Huebner JL, Stabler TV, Pieper CF, Shipes SW, Petry NA, Low PS, Shen J, McNearney TA, Mitchell P. Osteoarthritis Cartilage. 24(9):1613-21 (2016).
  20. Concordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients. Boogerd LS, Boonstra MC, Beck AJ, Charehbili A, Hoogstins CE, Prevoo HA, Singhal S, Low PS, van de Velde CJ, Vahrmeijer AL. Oncotarget. 7(14):17442-54 (2016).
  21. Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue. Roy J, Putt KS, Coppola D, Leon ME, Khalil FK, Centeno BA, Clark N, Stark VE, Morse DL, Low PS. Oncotarget. 7(12):14605-15 (2016).
  22. Synthesis and Preclinical Evaluation of Folate-NOTA-AI18F for PET Imaging of Folate Receptor-Positive Tumors. Chen Q, Meng X, McQuade P, Rubins D, Lin SA, Zeng Z, Haley H, Miller P, González Trotter D, Low PS. Mol Pharm 13(5):1520-7 (2016).
  23. Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors. Lv PC, Roy J, Putt KS, Low PS. Mol Pharm 13(5):1618-25 (2016).
  24. Synthesis and Evaluation of Folate-Conjugated Phenanthraquinones for Tumor-Targeted Oxidative Chemotherapy. Kumar A, Chelvam V, Sakkarapalayam M, Li G, Sanchez-Cruz P, Piñero NS, Low PS, Alegria AE. Open J Med Chem. 6(1):1-17 (2016).
  25. Substrate-Triggered Exosite Binding: Synergistic Dendrimer/Folic Acid Action for Achieving Specific, Tight-Binding to Folate Binding Protein. Chen J, van Dongen MA, Merzel RL, Dougherty CA, Orr BG, Kanduluru AK, Low PS, Marsh EN, Banaszak Holl MM. Biomacromolecules. 14;17(3):922-7 (2016).
  26. Intraoperative Molecular Diagnostic Imaging Can Identify Renal Cell Carcinoma. Guzzo TJ, Jiang J, Keating J, DeJesus E, Judy R, Nie S, Low P, Lal P, Singhal S. J Urol. 195(3):748-55 (2016).
  27. Intraoperative Molecular Imaging of Lung Adenocarcinoma Can Identify Residual Tumor Cells at the Surgical Margins. Keating JJ, Okusanya OT, De Jesus E, Judy R, Jiang J, Deshpande C, Nie S, Low P, Singhal S. Mol Imaging Biol. 18(2):209-18 (2016).
  28. Predicting Response to Therapy for Autoimmune and Inflammatory Diseases Using a Folate Receptor-Targeted Near Infrared Fluorescent Imaging. Kelderhouse L, Mahalingam S, Low PS. Mol Imaging Biol. 18(2):201-8 (2015).
  29. Quantification of tumor fluorescence during intraoperative optical cancer imaging. Judy RP, Keating JJ, DeJesus EM, Jiang JX, Okusanya OT, Nie S, Holt DE, Arlauckas SP, Low PS, Delikatny EJ, Singhal S. Sci Rep. 5:16208 (2015).
  30. Concurrent Detection of Cellular and Molecular Cancer Markers Using an Immunomagnetic Flow System. Huang W, Chang CL, Chan BD, Jalal SI, Matei DE, Low PS, Savran CA. Anal Chem. 87(20):10205-12 (2015).
  31. Biodistribution of Fracture-Targeted GSK3β Inhibitor-Loaded Micelles for Improved Fracture Healing. Low SA, Galliford CV, Yang J, Low PS, Kopeček J. Biomacromolecules. 16(10):3145-53 (2015).
  32. Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging. De Jesus E, Keating JJ, Kularatne SA, Jiang J, Judy R, Predina J, Nie S, Low P, Singhal S. Int J Mol Imaging. 2015:469047 (2015).
  33. Prediction of Response to Therapy for Autoimmune/Inflammatory Diseases Using an Activated Macrophage-Targeted Radioimaging Agent. Kelderhouse L, Robins, M, Rosenbalm K, Hoylman E, Mahalingam S, Low PS. Mol Pharm. 12(10):3547-55 (2015).
  34. The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary Adenocarcinomas. Kennedy GT, Okusanya OT, Keating JJ, Heitjan DF, Deshpande C, Litzky LA, Albelda SM, Drebin JA, Nie S, Low PS, Singhal S. Ann Surg. 262(4):602-9 (2015).
  35. Fluorescence assay of the interaction between hemoglobin and the cytoplasmic domain of erythrocyte membrane band 3. Sega MF, Chu H, Christian JA, Low PS. Blood Cells Mol Dis. 55(3):266-71 (2015).
  36. Folate Receptor Expression on Murine and Human Adipose Tissue. Hansen MJ, Bandara NA, Low PS. Inflamm Res. 64(9):697-706. (2015).
  37. Antiinflammatory Activity of a Novel Folic Acid Targeted Conjugate of the mTOR Inhibitor Everolimus. Lu Y, Parker N, Kleindl PJ, Cross VA, Wollak K, Westrick E, Stinnette TW, Gehrke MA, Wang K, Santhapuram HK, You F, Hahn SJ, Vaughn JF, Klein PJ, Vlahov IR, Low PS, Leamon CP. Mol Med. 21(1):584-96. (2015).
  38. Selective Tumor Targeting of Microtubule Disrupters, Desacetyl Vinblastine Hydrazide and Tubulysin B, via Conjugation to a Cholecystokinin 2 Receptor Antagonist. Wayua C, Roy J, Putt KS, Low PS. Mol Pharm. 6;12(7):2477-83 (2015).
  39. Intraoperative molecular imaging can identify lung adenocarcinomas during pulmonary resection. Okusanya OT, DeJesus EM, Jiang JX, Judy RP, Venegas OG, Deshpande CG, Heitjan DF, Nie S, Low PS, Singhal S. J Thorac Cardiovasc Surg. 150(1):28-35.e1 (2015).
  40. Assessment of folate receptor-β expression in human neoplastic tissues. Shen J, Putt KS, Visscher DW, Murphy L, Cohen C, Singhal S, Sandusky G, Feng Y, Dimitrov DS, Low PS. Oncotarget. 6(16):14700-9 (2015).
  41. Comparison of Nanoparticle Penetration into Solid Tumors and Sites of Inflammation: Studies Using Targeted and Non-Targeted Liposomes. Poh S, Chelvam V and Low PS. Nanomedicine (Lond). 10(9):1439-49 (2015).
  42. Targeting of folate receptor-beta on acute myeloid leukemia blasts with chimeric antigen receptor expressing T-cells. Lynn RC, Poussin MA, Kalota A, Feng Y, Low PS, Dimitrov DS, and Powell DJ. Blood. 125(22):3466-76 (2015).
  43. DUPA Conjugation of a Cytotoxic Indenoisoquinoline Topoisomerase I Inhibitor for Selective Prostate Cancer Cell Targeting. Roy J, Nguyen TX, Kanduluru AK, Venkatesh C, Lv W, Reddy PV, Low PS, Cushman M. J Med Chem. 58(7):3094-103 (2015).
  44. Synthesis and evaluation of a ligand targeting the somatostatin-2 receptor for drug delivery to neuroendocrine cancers. Li G, Low PS. Bioorg Med Chem Lett 25:1792-8 (2015).
  45. Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers. Wayua C, Low PS. J Nucl Med. 56:113-9 (2015).
  46. Principles in the design of ligand-targeted cancer therapeutic and imaging agents. Srinivasarao M, Low PS. Nat Rev Drug Discov 14:203-19 (2015).
  47. Folate receptor-β imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaque. Jager NA, Westra J, Golestani R, van Dam GM, Low PS, Tio RA, Slart RH, Boersma HH, Bijl M, Zeebregts CJ. J Nucl Med 55:1945-51 (2014).
  48. Molecular Imaging to Identify Tumor Recurrence Following Chemoradiation in a Hostile Surgical Environment. Okusanya OT, Deshpande C, Barbosa Jr EM, Aggarwal C, Simone II CB, Jiang J, Judy R, DeJesus E, Albelda S, Nie S, Low PS, and Singhal S. Mol Imaging 13:1-6 (2014).
  49. Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease. Wandersee NJ, Maciaszek JL, Giger KM, Hanson MS, Zheng S, Guo Y, Mickelson B, Hillery CA, Lykotrafitis G, Low PS, Hogg N. Blood Cells Mol Dis. 54:183-8 (2014).
  50. Folate receptor-β constitutes a marker for human proinflammatory monocytes. Shen J, Hilgenbrink AR, Xia W, Feng Y, Dimitrov DS, Lockwood MB, Amato RJ, Low PS. J Leukoc Biol 96:563-70 (2014).
  51. In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinoma. Sun JY, Shen J, Thibodeaux J, Huang G, Wang Y, Gao J, Low PS, Dimitrov DS, Sumer BD. Laryngoscope 124:E312-9 (2014).
  52. Folate receptor-β in activated macrophages: Ligand binding and receptor recycling kinetics. Varghese B, Vlashi E, Xia W, Lopez W, Paulos C, Reddy J, Xu L, Low PS. Mol Pharm11:3609-16 (2014).
  53. Evaluation of a cholecystokinin 2 receptor-targeted near infrared dye for fluorescence guided surgery of human cancers. Wayua C, Low P. Mol Pharm 11:468-76 (2014).
  54. Avidity Mechanism of Dendrimer-Folic Acid Conjugates. van Dongen M, Silpe J, Dougherty C, Kanduluru AK, Choi SK, Orr B, Low PS, Banaszak-Holl M. Mol Pharm 11:1696-706 (2014) 343. The effect of receptor occupancy on folate receptor internalization. Bandara NA, Hansen MJ, Low PS. Mol Pharm 11:1007-13 (2014).
  55. Assessment of folate receptor expression and folate uptake in multicentric lymphomas in dogs. Childress MO, Dhawan D, Leamon CP, Miller, MA, Ramos-Vara JA, Naughton JF, Low PS, Knapp DW. Am J Vet Rs 75:187-94. (2014).
  56. Chemical synthesis of staphyloferrin A and its application for Staphylococcus aureus detection. Pandy RK, Jarvis GG, Low PS. Org Biomol Chem 12:1707-10 (2014).
  57. Guiding principles in the design of ligand-targeted nanomedicines. Wang B, Galliford CV, Low PS. Nanomedicine (lond) 9:313-30 (2014).
  58. Use of folate-conjugated imaging agents to target alternatively activated macrophages in a murine model of asthma. Shen J, Chelvam V, Cresswell G, Low PS. Mol Pharm 10:1918-27 (2013).
  59. Spinal muscular atrophy: from gene discovery to clinical trials. Nurputra DK, Lai PS, Harahap NI, Morikawa S, Yamamoto T, Nishimura N, Kubo Y, Takeuchi A, Saito T, Takeshima Y, Tohyama Y, Tay SKh, Low PS, Saito K, Nishio H. Ann Hum Genet 77:435-63 (2013).
  60. Expression of functional folate receptors by human parathroid cells. Weber CJ, Müller S, Safley SA, gordon KB, Amancha P, Villinger F, Camp VM, Lipowska M, Sharma J, Müller C. Schibli R, Low PS, Leamon CP, Halkar RK. Surgery154:1385-93 (2013).
  61. A phase I study of folate immune therapy (EC90 vaccine administered with GPI-0100 adjuvant followed by EC17) in patients with renal cell carcinoma. Amato R, Shetty AV, Lu J, Ellis R, Low PS. J Immunother 36:268-75 (2013).
  62. Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors. Vlashi E, Kelderhouse L, Sturgis J, Low PS. ACS Nano 7:8573-82. (2013).
  63. Label-free detection of Stapylococcus aureus captured on imutable ligand arrays. Adak AK, Boley JW, Lyvers DP, Chiu GT, Low PS, Reifenberger R, Wei A.ACS Appl Mater Interfaces Jul 5:6404-11. (2013).
  64. Development of tumor-targeted near infrared probes for fluorescence guided surgery. Kelderhouse L, Chelvam V, Wayua C, Mahalingam S, Poh S, Kularatne S, Low PS. Bioconjug Chem 24:1075-80. (2013).
  65. Comparative analysis of folate derived PET Imaging Agents with [(18)F]-2-fluoro-2-deoxy-d-glucose using a rodent inflammatory paw model. Kularatne SA, Bélanger MJ, Meng X, Connolly BM, Vanko A, Suresch DL, Guenther I, Wang S, Low PS, McQuade P, Trotter DG. Mol Pharm 5:3103-11. (2013).
  66. A bacterial phosphatase- like enzyme of the malaria parasite Plasmodium falciparum
    possesses tyrosine phosphatase activity and is implicated in the regulation of band 3 dynamics during parasite invasion. Fernandez-Pol S, Slouka Z, Bhattacharjee S, Fedotova Y, Freed S, An X, Holder AA, Campanella E, Low PS, Mohandas N, Haldar K. Eukaryot Cell12:1179-91. (2013).
  67. Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma. Grapp M, Wrede A, Schweuzer M, Huiwel S, Galla HJ, Snaidero N, Simons M, Buckers J, Low PS, Urlaub H, Gartner J, Steinfield R. Nat Commun.4:2123. (2013).
  68. Small animal optical diffusion tomography with targeted fluorescence. Gaind, V.; Tsai H.R.; Webb, K.J.; Chelvam, V.; Low, P.S. J Opt Soc Am A Opt Image Sci Vis 30:1146-54. (2013).
  69. Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis. Gent, Y.Y.; Weijers, K.; Molthoff, C.F.; Windhorst, A.D.; Huisman, M.C.; Smith, D.E.; Kularatne, S.A.; Jansen, G.; Low, P.S.; Lammertsma, A.A.; van der Laken, C.J. Arthritis Res Ther. 15:R37. (2013).
  70. Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents. Cagle, P.T.; Zhai, Q.J.; Murphy, L.; Low, P.S. Arch Pathol Lab Med. 137:241-4. (2013).
  71. Oxygen regulates the band 3-ankyrin bridge in the human erythrocyte membrane. Stefanovic, M.; Puchulu-Campanella, E.; Kodippili, G.; Low, P.S. Biochem J 449:143-50 (2013).
  72. Changes in the properties of normal human red blood cells during in vivo aging. Franco, R.S.; Puchulu-Campanella, M.E.; Barber, L.A.; Palascak, M.B.; Joiner, C.H.; Low, P.S.; and Cohen, R.M. Am J Hematol 88:44-51 (2013).
  73. Identification of the components of a glycolytic enzyme metabolon on the human red blood cell membrane. Puchulu-Campanella, E.; Chu, H.; Anstee, D.J.; Tao, W.A.; Low, P.S. J Biol Chem 288:848-58 (2013).
  74. Targeting folate receptors to treat invasive urinary bladder cancer. Dhawan, D.; Ramos-Vara, J.A.; Naughton, J.F.; Chen,g L.; Low, P.S.; Rothenbuhler, R.; Leamon, C.P.; Parker, N.; Klein, P.J.; Vlahov, I.R.; Reddy, J.A.; Koch, M.; Murphy, L.; Fourez, L.M.; Stewart, J.C.; Knapp, D.W. Cancer Res 73:875-84. (2013).
  75. Analysis of the mobilities of band 3 populations associated with ankyrin protein and junctional complexes in intact murine erythrocytes. Kodippili, G.C.; Spector, J.; Hale, J.; Giger, K.; Hughes, M.R.; McNagny, K.M.; Birkenmeier, C.; Peters, L.; Ritchie, K.; Low, P.S. J Biol Chem 287:4129-38. (2012).
  76. New antimalarial indolone-N-oxides, generating radical species, destabilize the host cell membrane at early stages of Plasmodium falciparum growth: role of band 3 tyrosine phosphorylation. Pantaleo, A.; Ferru, E.; Vono, R.; Giribaldi, G.; Lobina, O.; Nepveu, F.; Ibrahim, H.; Nallet, J.P.; Carta, F.; Mannu, F.; Pippia, P.; Campanella, E.; Low, P.S., Turrini F. Free Radic Biol Med., 52:527-36. (2012).
  77. Identification of contact sites between ankyrin and band 3 in the human erythrocyte membrane. Grey, J.L.; Kodippili, G.C.; Simon, K.; Low, P.S. Biochemistry 51:6838-46. (2012).
  78. Imaging sites of infection using a 99mTc-labeled folate conjugate targeted to folate receptor positive macrophages. Henne, W.A.; Rothenbuhler, R.; Ayala-Lopez, W.; Xia, W.; Varghese, B.; Low P.S. Mol Pharm 9:1435-40 (2012).
  79. Identification of cytoskeletal elements that enclose the ATP pools that fuels the human red blood cell membrane cation pumps. Chu, H.; Puchulu-Campanella, E.; Galan, J.A.; Tao, W.A.; Low, P.S.; Hoffman, J.F. Proc Natl Acad Sci 109:12794-9 (2012).
  80. A folate receptor-α-specific ligand that targets cancer tissue and not sites of inflammation. Vaitilingam, B.; Chelvam, V.; Kularatne, S.A.; Poh, S.; Ayala-Lopez, W.; Low, P.S. J Nucl Med 53:1127 (2012).
  81. Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung:
    potential target for folate-linked therapeutic agents. Cagle, P.T.; Zhai, Q.; Murphy, L.; Low, P.S. Arch Pathol Lab Med 10:5858 (2012).
  82. Targeted folate receptor β fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaque. Jager, N.A.; Westra, J.; van Dam, G.M.; Teteloshvili, N; Tio, R.A.; Breek, J.C.; Slart, R.H.; Boersma, H; Low, P.S.; Bijl, M.; Zeebregts, C.J. J Nucl Med 53:1222-9 (2012).
  83. LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy. Johnson, E.O.; Chang, K.H.; Ghosh, S; Venkatesh, C.; Giger, K.; Low, P.S.; Shah, K. J Cell Sci 125:1204-16 (2012).
  84. Interaction of deoxyhemoglobin with the cytoplasmic domain of murine erythrocyte band 3. Sega, M.; Chu, H.; Christian, J.; and Low, P. S. Biochemistry, 51:3264-72 (2012).
  85. Label-free detection of a bacterial pathogen using an immobilized siderophore, deferoxamine. Kim, Y.; Lyvers, D.P; Wei, A.; Reifenberger, R. G. and Low, P. S. Lab Chip 12:971-6 (2012).
  86. Folate-linked drugs for the treatment of cancer and inflammatory diseases. Yang, J.; Vlashi, E.; Low, P. Subcell Biochem 56:163-79 (2012).
  87. Analysis of the mobilities of band 3 populations associated with the ankyrin and junctional complexes in intact murine erythrocytes. Kodippili, G.C.; Spector, j.; Hale, J.; Giger, K.; Hughes, M.R.; McNagny, K.M.; Birkenmeier, C.; Peters, L.; Ritchie, K.; Low, P.S.; J Biol Chem 287:4129-38 (2012).
  88. Synthesis and activity of folate conjugated didemnin B for potential treatment of inflammatory diseases. Henne, W.A.; Kularatne, S.A.; Ayala-López, W.; Doorneweerd, D.D.; Stinnette, T.W.; Lu, Y.; Low, P.S. Bioorg Med Chem Lett 22:709-12 (2012).
  89. Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys. Yang, J.J.; Kularatne, S.; Chen, X.; Low, P.S.; Wang, E.; Mol Pharm 9:310-7 (2012).
  90. The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer. Crane, L.M.; Arts, H.J.; Van Oosten, M.; Low, P.S.; van der Zee, A.G.; van Dam, G.M.; and Bart, J. Cellular Oncol 35:9-18 (2012).
  91. Folate receptor-α expression in resectable hepatic colorectal cancer metastases: patterns and significance. D’Angelica, M.D.; Ammor, J.; Gonen, M.; Klimstra, D.S.; Low, P.S.; Murphy, L.; Weiser, M.R.; Paty, P.B.; Fong, Y.; DeMatteo, R.P.; Allen, P.; Jarnagin, W.R.; Shia, J. Modern Pathol 9:1221-8 (2011).
  92. Detection of bacterial pathogens using siderophores. By Kim, Y; Low, P.S. From Abstracts of Papers, 241st ACS National Meeting & Exposition, Anaheim, CA, United States, March (2011).
  93. A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity. Feng, Yang; Shen, Jiayin; Streaker, Emily D.; Lockwood, Michael; Zhu, Zhongyu; Low, Philip S.; Dimitrov, Dimiter S. Arthritis Research & Therapy 13:R59 (2011).
  94. Single-cell electrical lysis of erythrocytes detects deficiencies in the cytoskeletal protein network. By Bao, N.; Kodippili, G. C.; Giger, K. M.; Fowler, V. M.; Low, P. S.; Lu, C.; Lab on a Chip (2011).
  95. Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate. Lu, Y.; Stinnette, T.W.; Westrick, E.; Klein, P.J.; Gehrke, M.A.; Cross, V.A.; Vlahov, I.R.; Low, P.S.; Leamon, C.P. Arthritis Res Ther 13:R56 (2011).
  96. Intraoperative Tumor-Specific Fluorescent Imaging in Ovarian Cancer by Folate Receptor-α Targeting: First In-Human Results. van Dam, G.M.; Themelis, G.; Crane, L. M. A.; Harlaar, N. J.; Pleijhuis, R. G.; Kelder, W.; Sarantopoulos, A.; de Jong, J. S.; Arts, H. J. G.; van der Zee, A. G. J.; Bart, J.; Low, P. S.; Ntziachristos, V. Nature Medicine 17: 1315-19 (2011).
  97. Regulation of Membrane-Cytoskeletal interactions by tyrosine phosphorylation of erythrocyte band 3. Ferru, E; Giger, K.; Pantaleo, A.; Campanella, E.; Grey, J.; Ritchie, K.; Vono, R.; Turrini, F.; and Low. P.S. Blood117: 5998-06 (2011).
  98. Bishydrazide Glycoconjugates for Lectin Recognition and Capture of Bacterial Pathogens. Adak, A. K.; Leonov, A. P.,; ding, N.; Thundimadathil, J.; Kularatne, S.; Low, P. S.; Wei, A. Bioconjug Chem 21:2065-75 (2010).
  99. Synthesis and Biological Analysis of Prostate-specific Membrane Antigen (PSMA)-Targeted Anti-Cancer Prodrugs. Kularatne, S. A.; Venkatesh, C.; Santhapuram, H. R.; Wang, K.; Vaitilingam, B.; Henne, W. A.; Low, P. S. J. Med. Chem 53:7767-77 (2010).
  100. Peroxiredoxin-2 Expression is increased in β-thalassemic Mouse Red Cells but is displaced from the Membrane as a Marker of Oxidative Stress. Matte, A.; Low P. S.; Turrini, F.; Bertoldi, M.; Campanella, M. E.; Spano, D.; Pantaleo, A.; Siciliano, A.; De Franceschi, L. Free Radic Biol Med 49:457-466 (2010).
  101. Erythrocyte Adducin: A Structural Regulator of the Red Blood Cell Membrane. Franco, T.; Low, P.S. Transfus. Clin. Bio. 17:87-94 (2010).
  102. Folate-Targeted Therapies for Cancer. Xia, W.; Low, P.S. J. Med. Chem53:6811-24 (2010).
  103. Selective Capture and Identification of Pathogenic Bacteria Using an Immobilized Siderophore. Doorneweerd, D. D.; Henne, W. A.; Reifenberger, R. G.; Low,, P. S. Langmuir 26:15424-9 (2010).
  104. Analysis of the Kinetics of Band 3 Diffusion in Human Erythroblasts during Assembly of the Erythrocyte Membrane Skeleton. Kodippili, G. C.; Spector, J.; Kang, G. E.; Liu, H.; Wickrema, A.; Ritchie, K.; Low, P.S. Br J Haemanol150:592-600 (2010).
  105. Deep-tissue Imaging of Intramolecular Fluorescence Resonance Energy-transfer Parameters. Vaibhav, G.; Kularatne, S.; Low, P.S.; Webb, Kevin J. Opt Let 35:1314-6 (2010).
  106. Imaging of Atherosclerosis in Apoliprotein E Knockout Mice: Targeting of a Folate-Conjugated Radiopharmaceutical to Activated Macrophages. Ayala-Lopez, W.; Xia, W.; Varghese, B.; Low, P. S. J. Nuclear Med 51:768-74 (2010).
  107. Targeting of nanoparticles: folate receptor. Kularatne, S. A.; Low, P. S. Methods Mol Biol 624:249-65 (2010).
  108. Evaluation of Band 3 Diffusion and Compartment Size by Single Particle Tracking. Spector, J.; Sullivan, C.; Labotka, R.; Ritchie, K.; Kodippili, G. C.; Low, P. S. Chemical Biochemistry 42:1851-1863 (2009).
  109. Strategy to Prevent Drug-related Hypersensitivity in Folate-targeted Hapten Immunotherapy of Cancer. Lu, Y.; Klein, P. J.; Westrick, E.; Zu, L. C.; Santhapuram, H. K.; Bloomfield, A.; Howard, S. J.; Vianov, I. R.; Ellis, P. R.; Low, P. S.; Leamon, C.P. AAPS J 11:628-38 (2009).
  110. Real Time, Noninvasive Imaging and Quantitation of the Accumulation of Ligand-targeted Drugs into Receptor-expressing Solid Tumors. Viashi, E.; Sturgis, J. E.; Thomas, M.; Low, P. S. Mol. Pharm 6:1868-75 (2009).
  111. Role of Band 3 in Regulating Metabolic Flux of Red Blood Cells. Lewis, I. A.; Campanella, M. E.; Markley, J. L.; Low, P. S. Proc Natl Acad Sci U.S.A.106:1851-20 (2009).
  112. Band 3 Catalyzes Sickle Hemoglobin Polymerization. Rotter, M. A.; Chu, H.; Low, P. S.; Ferrone, F.A. Biophys Chem 146:55-9 (2010).
  113. Functional Folate Receptor Alpha is elevated in the Blood of Ovarian Cancer Patients. Basal, E.; Eghbali-Fatourechi, G. Z.; Kalli, K.R.; Hartmann, L.C.; Goodman, K. M.; Goode, E. L.; Kamen, B. A.; Low, P. S.; Knutson, K. L. PLoS One. 4:e6292 (2009).
  114. Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions. Yuan, Y.; Nymoen, D. A.; Dong, H. P.; Bjorang, O.; Shih, I. M.; Low, P. S.; Trope, C. G.; Davidson, B. Hum. Pathol 40:1453-60 (2009).
  115. Ligand-Targeted Delivery of Small Interfering RNAs to Malignant Cells and Tissues. Thomas, M.; Kularatne, S. A.; Qi, L.; Kleindl, P.; Leamon, C. P.; Hansen, M. J.; Low, P. S. Ann. N.Y. Acad. Sci 1175:32–9 (2009).
  116. Where Spectrin Snuggles with Ankyrin. Low, P. S. Blood 113:5372-5373 (2009).
  117. Design, Synthesis, and Pre-clinical Evaluation of Prostate-Specific Membrane Antigen (PSMA)-Targeted Tc-99m-Radioimaging Agents. Kularatne, S. A.; Zhou, Z. G.; Yang, J.; Post, C. B.; Low, P. S. Mol Pharm 6:790-800 (2009).
  118. Assessment of Disease Activity to Rheumatoid Arthritis Using a Novel Folate Targeted Radiopharmaceutical Folatescan™. Matteson, E. L.; Lowe, V. J.; Prendergast, F. G.; Crowson, D. S.; Moder, K. G.; Morgenstern, D. E.; Messmann, R. A.; Low, P. S. Clinical and Experimental Rheumatology 27:253-259 (2009).
  119. Folate-Targeted Therapeutic and Imaging Agents for Cancer. Low, P. S.; Kularatne, S. A. Curr Opin Chem Biol 13:256-62 (2009).
  120. Adducin forms a Bridge between the Erythrocyte Membrane and its Cytoskeleton and Regulates Membrane Cohesion. Anong, W. A.; Franco, T.; Chu, H.; Weis, T. L.; Devlin, E. E.; Bodine, D. M.; An, X.; Narla, M.; Low, P. S. Blood114:1904-12 (2009).
  121. Prostate-Specific Membrane Antigen (PSMA)-Targeted Imaging and Therapy of Prostate Cancer Using a PSMA Inhibitor as a Homing Ligand. Kularatne, S. A.; Wang, K.; Santhapuram, H. K. R.; Low, P. S. Mol Pharm 6, 780-89 (2009).
  122. Imaging of the Diffusion of Single Band 3 Molecules on Normal and Mutant Erythrocytes. Koippili, G. C.; Spector, J.; Sullivan, C.; Kuypers, F. A.; Labotka, R.; Gallagher, P. G.; Richie, K.; Low, P. S. Blood 113:6237-45 (2009).
  123. Folate-Targeted Hapten Immunotherapy of Adjuvant-Induced Arthritis: Comparison of Hapten Potencies. Yi, Y. S.; Ayala-Lopez, W.; Kularatne, S. A.; Low, P. S. Mol Pharm 6:1228-36 (2009).
  124. A Functional Folate Receptor is Induced during Macrophage Activation and can be used to Target Drugs to Aactivated Mmacrophages. Xia, W.; Hilgenbrink, A. R.; Matteson, E. L.; Lockwood, M. B.; Cheng J. X.; Low P. S. Blood 113:438-46 (2009).
  125. Fast Release of Lipophilic Agents from Circulating PEG-PDLLA Micelles Revealed by in Vivo Forster Resonance Energy Transfer Imaging. Chen, H.; Kim, S.; He, W.; Wang, H.; Low, P. S.; Park, K.; Cheng, J. X. Langmuir 24:5213-17 (2008).
  126. A Role for the Proton-coupled Folate Transporter (PCFT - SLC46A1) in Folate Receptor-mediated Endocytosis. Zhao, R.; Yanhua, S. H. M.; Wang, Y.; Campanella, E.; Low, P. S.; Goldman, I. D. J Biol Chem 284:4267-74 (2008).
  127. Quantitation of Circulating Tumor Cells in Blood Samples from Ovarian and Prostate Cancer Patients Using Tumor-specific Fluorescent ligands. He, W.; Kularatne, S. A.; Kalli, K. R.; Prendergast, F. G.; Amato, R. J.; Klee, G. G.; Hartman, L. C.; Low, P. S. Int. Journal Cancer 123:1968-73 (2008).
  128. Two-photon Luminescence Imaging of bacillus Spores using Peptide-functionalized Gold Nanorods. He, W.; Henne, W.A.; Wei, Q.; Zhao, Y.; Doorneweerd, D. D.; Cheng, J. X.; Low, P. S.; Wei, A. Nano Res 1:450-56 (2008).
  129. Low-dose Radiation Potentiates the Therapetic Efficacy of Folate Receptor-targeted Hapten Therapy. Sega, E. I.; Lu, Y.; Ringor, M.; Leamon, C. P.; Low, P. S. Int J Radiat Oncol Biol Phys 71:559-66 (2008).
  130. Characterization of Glycolytic Enzyme Interactions with Murine Erythrocyte Membranes in Wild-type and Membrane Protein Knockout Mice. Campanella, M. E.; Chu, H.; Wandersee, N. J.; Peters, L. L.; Mohandas, N.; Gilligan, D. M.; Low, P. S. Blood 112:3900-06 (2008).
  131. Osteopontin Regulates Actin Cytoskeleton and Contributes to Cell Proliferation in Primary Erythroblasts. Kang, J. A.; Zhou, Y.; Weis, T. L.; Liu, H.; Ulaszek, J.; Satgurunathan, N.; Zhou, L.; van Besien, K.; Crispino, J.; Verma, A.; Low, P. S.; Wickrema, A. J Biol Chem 283:6997-7006 (2008).
  132. Receptor-mediated Delivery of siRNAs by Tethered Nucleic Acid Base-paired Interactions. Zhang, K.; Wang, Q,; Xie, Y,; Mor, G,; Sega, E.; Low, P. S.; Huang. Y. RNA 14:577-83
  133. Immunohistochemical Expression of Folate Receptor Alpha in Colorectal Carcinoma: Patterns and Biological Significance. Shia, J.; Klimstra, D. S.; Nitzkorski, J. R.; Low, P. S.; Gonen, M.; Landmann, R.; Weiser, M. R.; Franklin, W. A.; Prendergast, F. G.; Murphy, L.; Tang, L. H.; Temple, L.; Guillem, J. G.; Wong, W. D.; Paty, P. B. Hum. Pathol 39:498-505 (2008).
  134. Folate Receptor Alpha as a Tumor Target in Epithelial Ovarian Cancer. Kalli, K. R.; Oberg, A. L.; Keeney, G. L.; Christianson, T. J.; Low, P. L.; Knutson, K. L.; Hartmann, L. C.; Gynecol Oncol 108:619-26 (2008).
  135. Tumor Detection using Folate Receptor-targeted Imaging Agents. Sega, E.I. andLow, P.S. Cancer Metastasis Rev 27:655–64 (2008).
  136. Cholesterol Level Regulates Endosome Motility via Rab Proteins. Chen, H.; Yang, J.; Low, P. S.,; Cheng, J. X. Biophys J. 94:1508-20 (2008).
  137. Characterization of the Deoxyhemoglobin Binding Site on Human Erythrocyte Band 3: Implications for O2 Regulation of Erythrocyte Properties. Chu, H.; Breite, A.; Ciraolo, P.; Franco, R. S.; Low, P. S. Blood 111:932-8 (2008).
  138. Discovery and Development of Folic-Acid-Based Receptor Targeting for Imaging and Therapy of Cancer and Inflammatory Diseases. Low, P. S.; Henne, W. A.; Doorneweerd, D. D. Accounts of Chemical Research 41:120-29 (2008).
  139. Immunomagnetic Diffractometry for Detection of Diagnostic Serum Markers. Acharya, G.; Chang, C. L.; Doorneweerd, D. D.; Vlashi, E.; Henne, W. A.; Hartmann, L. C.; Low, P. S.; Savran, C. A. J Am Chem Soc 129:15824-29 (2007).
  140. The Optimal Strategy for Drug Targeting. Low, P. S. Mol. Pharm 4:629-30 (2007).
  141. Label-free Optical Detection of Anthrax-Causing Spores. Acharya, G.; Doorneweerd, D. D.; Chang, C. L.; Henne, W. A.; Low, P. S.; Savran, C. A. J Am Chem Soc 129:732-33 (2007).
  142. Characterization of the pH of Folate Receptor-containing Endosomes and the Rate of Hydrolysis of Internalized Acid-labile Folate-drug Conjugates. Yang, J.; Chen,, H.; Vlahov, I. R.; Cheng, J. X.; Low, P. S. Pharmacol Exp Ther 321:462-68 (2007).
  143. Folate Receptor Overexpression is Associated with Poor Outcome in Breast Cancer. Hartmann, L. C.; Keeney, G. L.; Lingle, W. L.; Christianson, T. J.; Varghese, B.; Hillman, D.; Oberg, A. L.; Low, P. S. Int J Cancer 121:938-42 (2007).
  144. An 11-amino Acid Beta-hairpin Loop in the Cytoplasmic Domain of Band 3 is Responsible for Ankyrin Binding in Mouse Erythrocytes. Stefanovic, M.; Markham, N. O.; Parry, E. M.; Stefanovic, M.; Markham, N. O.; Parry, E. M.;Proc Natl Acad Sci USA 104:13972-77 (2007).
  145. Folate-targeted Dinitrophenyl Hapten Immunotherapy: Effect of Linker Chemistry on Antitumor Activity and Allergic Potential. Lu, Y.; You, F.; Vlahov, I.; Westrick, E.; Fan, M.; Low, P. S.; Leamon, C. P. Mol Pharm 4:695-706 (2007).
  146. Depletion of Folate-Receptor-Positive Macrophages Leads to Alleviation of Symptoms and Prolonged Survival in Two Murine Models of Systemic Lupus Erythematosus. Varghese,, B,; Haase,, N.; Low, P. S. Mol Pharm 4:679-85 (2007).
  147. In Vivo Quantitation of Rare Circulating Tumor Cells by Multiphoton Intravital Flow Cytometry. He, W.; Wang, H.; Hartmann, L. C.; Cheng, J. X.; Low, P. S.Proc Natl Acad Sci USA104:11760-65 (2007).
  148. Preclinical Pharmacokinetics, Tissue Distribution, and Antitumor Activity of a Folate-hapten Conjugate-targeted Immunotherapy in Hapten-immunized Mice. Lu, U.; Xu, L. C.; Parker, N.; Westrick, E.; Reddy, Westrick, E,; Reddy, J. A.; Vetzel, M.; Low, P. S.; Leamond, C. P. Mol Cancer Ther 5:3258-67 (2006).
  149. Rate of Rupture and Reattachment of the Band 3-Ankyrin Bridge in the Human Erythrocyte Membrane. Anong, W. A.; Weis, T. L.; Low, P. S. J. Biol. Chem. 281:22360-66 (2006).
  150. Synthesis and activity of a folate peptide camptothecin prodrug. Henne, W. A.; Doorneweerd, D. D.; Hilgenbrink, A. R.; Kularatne, S. A.; Low, P. S. Bioorg Med Chem Lett 16:5350-55 (2006).
  151. T-cell Immunity to the Folate Receptor Alpha is Prevalent in Women with Breast or Ovarian Cancer. Kuntson, K. L.; Krco, C. J.; Erslome. C. L.; Erksine, C. L.; goodman, K.; Kelemen., L. E.; Wettstein, P. S.; Hartman, L. C.; Kalli, K. R.Clin. Oncol. 24:4254-61 (2006).
  152. Evaluation of Disulfide Reduction during Receptor-mediated Endocytosis by using FRET Imaging. Yang, J.; Chen, H.; Vlahov, I. R.; Cheng, J. X.; Low, P. S.Proc. Natl. Acad. Sci. USA 103:13872-77 (2006).
  153. Mapping of Glycolytic Enzyme-binding Sites on Human Erythrocyte Band 3. Chu, H.; Low, P. S. Biochem. J. 400:143-51 (2006).
  154. Detection of Folate Binding Protein with Enhanced Sensitivity using a Functionalized Quartz Crystal Microbalance Sensor. Henne, W. A.; Doorneweerd, D. D.; Lee, J.; Low, P. S.; Savran, C. Anal. Chem. 78:4880-84 (2006).
  155. Folate-targeted Immunotherapy Effectively Treats Established Adjuvant and Collagen-induced Arthritis. Paulos, C. M.; Varghese, B.; Widmer, R.; Breur, G. J.; Vlashi, E.; Low, P. S. Arthritis Research and Therapy 8:R77 (2006). Full text available online: http://arthritis-research.com/content/pdf/ar1944.pdf.
  156. Detection of Bacillus Subtilis Spores using Peptide-functionalized Cantilever Arrays. Dhayal, B.; Henne, W. A.; Doorneweerd, D. D.; Reifenberger, R. G.; Low, P. S. J. Am. Chem. Soc. 128:3716-21 (2006).
  157. Erythrocyte Adhesion is Modified by Alterations in Cellular Tonicity and Volume. Wandersee, N. J.; Punzalan, R. C.; Rettig, M. P.; Kennedy, M. D.; Pajewski, N. M.; Sabina, R. L.; Scott, J. P.; Low, P. S.; Hillery, C. A. British Jou. of Haematology 131:366-77 (2005).
  158. In vitro and in vivo Two-Photon Luminescence Imaging of Single Gold Nanorods. Wang, H.; Huff, T. B.; Zweifel, D. A.; He, W.; Low, P.S.; Wei, A.; Cheng, J. X. Proc. Natl. Acad. Sci. U.S.A. 102:15752-56 (2005).
  159. Folate Receptor-mediated Drug Targeting: From Therapeutics to Diagnostics. Hilgenbrink, A. R.; Low, P. S. J. Pharmaceutical Sciences 94:2135-46 (2005).
  160. Increased Uptake of Folate Conjugates by Activated Macrophages in Experimental Hyperlipidemia. Antohe, F.; Radulescu, L.; Puchianu, E.; Kennedy, M. D.; Low, P. S.; Simionescu, M. Cell Tissue Res. 320:277-85 (2005).
  161. Folate Receptor-targeted Immunotherapy: Induction of Humoral and Cellular Immunity against Hapten-Decorated Cancer Cells. Lu, Y.; Sega, E.; Low, P. S. Int. J. Cancer 116:710-19 (2005).
  162. Effector-induced Syk-mediated Phosphorylation in Human Erythrocytes. Clari, G.; Bordin, L.; Ion-Popa, F.; Brunati, A. M.; Low, P. S. Biochim. Biophys. Acta 1745:20-28 (2005).
  163. Statistical Approach for Detection and Localization of a Fluorescing Mouse Tumor in Intralipid. Milstein, A. B.; Kennedy, M. D.; Low, P. S.; Bouman, C. A.; Webb, K. J. Appl. Opt. 44:2300-10 (2005).
  164. The N-terminal 11 Amino Acids of Human Erythrocyte Band 3 are Critical for Aldolase Binding and Protein Phosphorylation: Implications for Band 3 Function. Perrotta, S.; Borriello, A.; Scaloni, A.; De Franceschi, L.; Brunati, A. M.; Turrini, F.; Nigro, V.; del Giudice, E. M.; Nobili, B.; Conte, M. L.; Rossi, F.; Iolascon, A.; Donella-Deana, A.; Zappia, V.; Poggi, V.; Anong, W.; Low, P. S.; Narla, M.; Ragione, F. D. Blood 106:4359-66 (2005).
  165. Folate Receptor Expression in Carcinomas and Normal Tissues Determined by a Quantitative Radioligand Binding Assay. Parker, N.; Turk, M. J.; Westrick, E.; Lewis, J. D.; Low, P. S.; Leamon, C. P. Analytical Biochem. 338:284-93 (2005).
  166. Folate Receptor Expression in Carcinomas and Normal Tissues Determined by a Quantitative Radioligand Binding Assay. Parker, N.; Turk, M. J.; Westrick, E.; Lewis, J. D.; Low, P. S.; Leamon, C. P. Analytical Biochem. 338:284-93 (2005).
  167. Receptor-mediated Drug Delivery. Leamon, C .P.; Low, P. S. Drug Delivery: Principles and Applications pp. 167-187. (2005). (eds. B. Wang, T.J. Siahaan and R. Soltero.) John Wiley & Sons, Inc. Hoboken, NJ, USA.
  168. Assembly and Regulation of a Glycolytic Enzyme Complex on the Human Erythrocyte Membrane. Campanella, M. E.; Chu, H.; P. S. Low. Proc. Natl. Acad. Sci. 102:2402-7 (2005).
  169. Folate Receptor Mediated Targeting of Liposomal Drugs to Cancer Cells. Stephenson, S. M.; Low, P. S.; Lee, R. J. Methods in Enzymology 387:33-50 (2004)
  170. Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery. Paulos, C. M.; Reddy, J. A.; Leamon, C. P.; Turk, M. J.; Low, P. S. Mol. Pharmacol. 66:1406-14 (2004).
  171. Ligand Binding and Kinetics of Folate Receptor Recycling in Vivo: Impact on Receptor-Mediated Drug Delivery. Paulos, C. M.; Reddy, J. A.; Leamon, C. P.; Turk, M. J.; Low, P. S. Mol. Pharmacol. 66:1406-14 (2004).
  172. Folate-Conjugated Liposomes Preferentially Target Macrophages Associated with Ovarian Carcinoma. Turk, M. J.; Waters, D. J.; Low, P. S. Cancer Lett. 213:165-72 (2004).
  173. Folate Receptor-Mediated Targeting of Therapeutic and Imaging Agents to Activated Macrophages in Rheumatoid Arthritis. Paulos, C. M.; Turk, M. J.; Breur, G. J.; Low, P. S. Advanced Drug Delivery Reviews 56:1205-17 (2004).
  174. Folate Receptor-Targeted Immunotherapy of Cancer: Mechanism and Therapeutic Potential. Lu, Y.; Sega, E.; Leamon, C. P.; Low, P. S. Advanced Drug Delivery Reviews 56:1161-76 (2004).
  175. Folate Receptor-Targeted Drugs for Cancer and Inflammatory Diseases. Low, P. S.; Antony, P. Advanced Drug Delivery Reviews 56:1055-58 (2004)
  176. Uptake and Trafficking of Fluorescent Conjugates of Folic Acid in the Intact Kidney Using Intra-Vital 2-Photon Microscopy. Sandoval, R. M.; Kennedy, M. D.; Low, P. S.; Molitoris, B. A. Am. J. Physiol. Cell Physiol. 287:C517-26 (2004).
  177. Erythrocyte detergent-resistant membrane proteins: their characterization and selective uptake during malarial infection. Murphy, S. C.; Samuel, B. U.; Harrison, T.; Speicher, K. D.; Speicher, D. W.; Reid, M. E.; Prohaska, R.; Low, P. S.; Tanner, M. J.; Mohandas, N.; Haldar, K. Blood 103:1920-28 (2004).
  178. Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as Potential Folate-receptor-targeted PET Radiopharmaceuticals. Mathias, C. J.; Lewis, M. R.; Reichert, D. E.; Laforest, R.; Sharp, T. L.; Lewis, J. S.; Yang, Z. F.; Waters, D. J.; Snyder, P. W.; Low, P. S.; Welch, M. J.; Green, M. A. Nuclear Med. and Biol. 30:725-31 (2003).
  179. Altered Erythrocyte Endothelial Adherence and Membrane Phospholipid Asymmetry in Hereditary Hydrocytosis. Gallagher, P. G.; Chang, S. H.; Rettig, M. P.; Neely, J. E.; Hillery, C. A.; Smith, B. D.; Low, P. S. Blood 101:4625-27 (2003).
  180. Evaluation of Folate Conjugate Uptake and Transport by the Choroid Plexus of Mice. Kennedy, M. D.; Jallad, K. N.; Lu, J.; Low, P. S.; Ben–Amotz, D. Pharm. Res. 20:714-19(2003).
  181. Optical Imaging of Metastatic Tumors Using a Folate-Targeted Fluorescent Probe. Kennedy, M. D.; Jallad, K. N.; Thompson, D. H.; Ben-Amotz, D.; Low, P. S. J. Biomed. Optics 8:636-41 (2003).
  182. Immunotherapy of Folate Receptor-Expressing Tumors: Review of Recent Advances and Future Prospects. Lu, J.; Low, P. S. J. Controlled Release 91:17-29 (2003).
  183. Targeted Immunotherapy of Cancer: Development of Antibody-induced Cellular Immunity. Lu, Y.; Low, P. S. J. Pharmacy and Pharmacology 55:163-67, 2003.
  184. Identification of a Critical Ankyrin Binding Loop on the Cytoplasmic Domain of Erythrocyte Membrane Band 3 by Crystal Structure Analysis and Site-directed Mutagenesis, Chang, S. H.; Low, P. S. J. Biol. Chem. 278:6879-84 (2003).
  185. An Osmotically Induced Cytosolic Ca2+ Transient Activates Calcineurin Signaling to Mediate Ion Homeostasis and Salt Tolerance of Saccharomyces cerevisiae. Matsumoto, T. K.; Ellsmore, A. J.; Cessna, S. G.; Low, P. S.; Pardo, J. M.; Bressan, R. A.; Hasegawa, P. M. J. Biol. Chem. 277:33075-80 (2002).
  186. Synthesis and Evaluation of 99mTc(CO)3-DTPA-Folate as a Folate-Receptor-Targeted Radiopharmaceutical. Trump, D. P.; Mathias, C. J.; Yang, Z. F.; Low, P. S.; Marmion, M. A.; Green, M. A. Nucl. Med. Biol. 29:569-73 (2002).
  187. Phorbol Ester Stimulates a Protein Kinase C-mediated Agatoxin-TK-sensitive Calcium Permeability Pathway in Human Red Blood Cells. Andrews, D. A.; Yang, L.; Low, P. S. Blood 100:3392-99 (2002).
  188. Protein Kinase C Activation Induces Phosphatidylserine Exposure on Red Blood Cells. de Jong, K.; Rettig, M. P.; Low, P. S.; Kuypers, F. A. Biochem. 41:12562-67 (2002).
  189. Heme Redox Properties of S-nitrosated Hemoglobin A and Hemoglobin S: Implications for Interactions of Nitric Oxide with Normal and Sickle Red Blood Cells. Bonaventura, C.; Taboy, C. H.; Low, P. S.; Stevens, R. D.; Lafon, C.; Crumbliss, A. L. J. Biol. Chem. 277:14557-63 (2002).
  190. Folate-targeted Imaging of Activated Macrophages in Rats with Adjuvant-Induced Arthritis. Turk, M. J.; Breur, G. J.; Widmer, W. R.; Paulos, C. M.; Xu, L. C.; Grote, L. A.; Low, P. S. Arthritis & Rheumatism 46:1947-55 (2002).
  191. Folate-mediated Delivery of Macromolecular Anticancer Therapeutic Agents. Lu, Y.; Low, P. S. Advanced Drug Delivery Reviews 54:675-93 (2002).
  192. Synthesis and Evaluation of Taxol-Folic Acid Conjugates as Targeted Antineoplastics. Lee, J. W.; Lu, J. Y.; Low, P. S.; Fuchs, P. L. Bioorganic & Medicinal Chem. 10:2397-414 (2002).
  193. Headpiece Domain of Dematin is Required for the Stability of the Erythrocyte Membrane. Khanna, R.; Chang, S. H.; Andrabi, S.; Azam, M.; Kim, A.; Rivera, A.; Brugnara, C.; Low, P. S.; Liu, S. C.; Chishti, A. H. Proc. Natl. Acad. Sci. 99:6637-42 (2002).
  194. Folate-targeting of Haptens to Cancer Cell Surfaces Mediates Immunotherapy of Syngeneic Murine Tumors. Lu, Y.; Low, P. S. Cancer Immunol. Immunother. 51:153-62 (2002).
  195. Characterization of a Novel pH-sensitive Peptide that Enhances Drug Release from Folate-targeted Liposomes at Endosomal pHs. Turk, M. J.; Reddy, J. A.; Chmielewski, J. A.; Low, P. S. Biochim. Biophys. Acta 1559:56-68 (2002).
  196. Analysis of Integral Membrane Protein Contributions to the Deformability and Stability of the Human Erythrocyte Membrane. Van Dort, H. M.; Knowles, D. W.; Chasis, J. A.; Lee, G.; Narla, N.; Low, P. S. Jou. Biol. Chem. 276:46968-74 (2001).
  197. Activation of the Oxidative Burst in Aequorin-transformed Nicotiana tabacum cells is Mediated by Protein Kinase- and Anion Channel-dependent Release of Ca2+ from Internal Stores. Cessna, S. G.; Low, P. S. Planta214:126-34 (2001).
  198. Effect of pH on the Self-Association of Erythrocyte Band 3 In Situ, Rettig, M. P.; Orendorff, C.J.; Campanella, E.; Low, P. S. Biochim. Biophys. Acta1515:72-81 (2001).
  199. Characterization of the Reversible Conformational Equilibrium in the Cytoplasmic Domain of Human Erythrocyte Membrane Band 3*. Zhou, J.; Low, P. S. J. Biol. Chem. 76:38147-51 (2001).
  200. Retargeting of Viral Vectors to the Folate Receptor Endocytic Pathway. Reddy, J. A.; Clapp, D. W.; Low, P. S. J. Controlled Release 74:77-82 (2001).
  201. Regulation of the Glycophorin C-protein 4.1 Membrane-to-Skeleton Bridge and Evaluation of Its Contribution to Erythrocyte Membrane Stability. Chang, H. S.; Low, P. S. J. Biol. Chem. 276:22223-30 (2001).
  202. Measurement of Stress-induced Ca2+ Pulses in Single Aequorin-transformed Tobacco Cells. Cessna, S. G.; Messerli, M. A.; Robinson, K. R.; Low, P. S. Cell Calcium 30:151-6 (2001).
  203. An Apoplastic Ca2+ Sensor Regulates Internal Ca2+ Release in Aequorin-transformed Tobacco Cells. Cessna, S. G.; Low, P. S. J. Biol. Chem. 276:10655-62 (2001).
  204. Involvement of Mitogen-activated Protein Kinase Activation in the Signal-transduction Pathways of the Soya Bean Oxidative Burst. Taylor, A. T.; Kim, J.; Low, P. S. Biochem. J. 355:795-803 (2001).
  205. Localization of Mutations Leading to Altered Cell Shape and Anion Transport in the Crystal Structure of the Cytoplasmic Domain of Band 3. Low, P. S.; Zhang, D.; Bolin, J. T. Blood Cells, Molecules, and Diseases 27:81-84 (2001).
  206. Folate-mediated Targeting: From Diagnostics to Drug and Gene Delivery. Leamon, C. P.; Low, P. S. Drug Discovery Today 6:44-51 (2001).
  207. Synthesis of 99mTc-DTPA-Folate and Evaluation as a Folate-Receptor-Targeted Radiopharmaceutical. Mathias, C. J.; Hubers, D.; Low, P. S.; Green, M. A. Bioconjugate Chem. 11:253-57 (2000).
  208. Plasmodium falciparum Histidine-rich Protein 1 Associates with the Band 3 Binding Domain of Ankyrin in the Infected Red Cell Membrane. Magowan, C.; Nunomura, W.; Waller, K.; Yeung, J.; Liang, J.; Van Dort, H.; Low, P. S.; Coppel. R. Biochimica et Biophysica Acta 1502:461-70 (2000).
  209. Oxalic Acid, a Pathogenicity Factor for Sclerotinia sclerotiorum, Suppresses the Plant Oxidative Burst of the Host Plant. Cessna S. G.; Sears, V. E.; Dickman, M. B.; Low, P. S. Plant Cell 12:2191-99 (2000).
  210. Homologous and heterologous desensitization and synergy in pathways leading to the soybean oxidative burst. Chandra, S.; Cessna, S. G.; Yahraus, T.; Devine, R.; Low, P. S. Planta 211:736-42 (2000).
  211. Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3. Zhang, D.; Kiyatkin, A.; Bolin, J.; Low, P. S. Blood 96:2925-33 (2000).
  212. Lysophosphatidic Acid Opens a Ca++ Channel in Human Erythrocytes. Yang, L. Andrews, D. A.; Low, P. S. Blood 95:2420-25 (2000).
  213. Enhanced Folate Receptor Mediated Gene Therapy Using a Novel pH-Sensitive Lipid Formulation. Reddy, J. A.; Low, P. S. J. Controlled Release64:27-37 (2000).
  214. Folate as a Targeting Device for Proteins Utilizing Folate Receptor-mediated Endocytosis. Lee, R. J.; Low, P. S. Methods in Molecular Medicine (ed. G.E. Francis and Cristina Delgado), Humana Press. vol. 25, chapter 5, 69-76 (2000).
  215. Synthesis and Evaluation of folate-Bis (Thiosemicarbazone) and Folate-Cyclam Conjugates for Possible Use as Folate-Receptor-Targeted Copper Radiopharmaceuticals. Ke, C.Y.; Mathias, C. J.; Yang, Z.F.; Luo, J.; Low, P. S.; Waters, D. J.; Green, M. A. J. Labelled Compounds and Radiopharmaceuticals42:S821-23 (1999).
  216. Oligogalacturonic Acid and Chitosan Reduce Stomatal Aperture by Inducing the Evolution of Reactive Oxygen Species from Guard Cells of Tomato andCommelina communis. Lee, S.; Choi, H.; Suh, S.; Doo, I.S.; Oh, K.Y.; Choi, E. J.; Taylor, A. T. S.; Low, P. S.; Lee, Y. Plant Phys.121:147‑52 (1999).
  217. Optimization of Folate-Conjugated Liposomal Vectors for Folate Receptor-Mediated Gene Therapy. Reddy J. A.; Dean, D.; Kennedy, M. D.; Low, P. S. J. Pharmaceutical Sciences 88:1112-8 (1999).
  218. Folate-Targeted Enzyme Prodrug Cancer Therapy Utilizing Penicillin-V Amidase and a Doxorubicin Prodrug. Lu, J. Y.; Lowe, D. A.; Kennedy, M. D.; Low, P. S. J. Drug Targeting 7:43-53 (1999).
  219. Role of Red Blood Cells in Thrombosis. Andrews, D. A. DVM; Low, P.S. Current Opinion in Hematology 6:76-82 (1999).
  220. Expression and Functional Characterization of the b-isoform of the Folate Receptor on CD34+ Cells. Reddy J. A.; Haneline, L. S.; Srour, E. F.; Antony, A. C.; Clapp, D. W.; Low, P. S. Blood 93:3940-48 (1999).
  221. Receptor-Mediated Targeting of 67Ga-Deferoxamine-Folate to Folate-Receptor-Positive Human KB Tumor Xenografts. Mathias, C. J.; Wang, S.; Low, P. S.; Waters, D. J.; Green, M. A. Nuclear Medicine & Biology 26:23-25 (1999).
  222. South-East Asian Ovalocytic (SAO) Erythrocytes have a Cold Sensitive Cation Leak: Implications for in vitro Studies on Stored SAO Red Cells. Bruce L. J.; Ring, S. M.; Ridgwell, K.; Reardon, D. M.; Seymour, C. A.; Van Dort, H. M.; Low, P. S.; Tanner, M. J. A. Biochem. Biophys. Acta 1416:258‑70 (1999).
  223. Riboflavin-mediated delivery of a macromolecule into cultured human cells. Holladay, S. R.; Yang, Z.-F.; Kennedy, M. D.; Leamon, C. P.; Lee, R. J.; Jayamani, M.; Mason, T.; Low, P. S. Biochimica et Biophysica Acta 1426:195-204 (1999).
  224. Evaluation of Biochemical Changes During In Vivo Erythrocyte Senescence in the Dog. Rettig, M.; Low, P. S.; Gimm, A.; Narla, M.; Wang, J.; Christian, J. A. Blood 93:376-84 (1999).
  225. Characterization of the Hypertonically-Induced Tyrosine Phosphorylation of Erythrocyte Band 3. Minetti, G.; Seppi, C.; Ciana, A.; Balduini, C.; Low, P. S.; Brovelli, A. Biochem. J. 335:305-11 (1998).
  226. Folate-Mediated Targeting of Therapeutic and Imaging Agents to Cancers. Reddy, J. A.; Low, P. S. Crit. Rev. Ther. Drug Carrier Systems 15:587-627 (1998).
  227. Diplasmenylcholine-Folate Liposomes: An Efficient Vehicle for Intracellular Delivery of Hydrophilic Compounds. Rui, Y. J.; Wang, S.; Low, P. S.; Thompson, D. H. J. Am. Chem. Soc. 120:11213-18 (1998).
  228. Hypo-osmotic Shock of Tobacco Cells Stimulates Ca2+ Fluxes Deriving First from External and then Internal Ca2+ Stores. Cessna, S. G.; Chandra, S.; Low, P. S. J. Biol. Chem. 273:27286-91 (1998).
  229. How Old are Dense RBC? The Dog’s Tale. Christian, J. A.; Wang, J.; Rettig, M.; Kiyatkina, N.; Low, P. S. Blood 92:2590-604 (1998).
  230. The FERM domain: A unique module involved in the linkage of cytoplasmic proteins to the membrane. Chishti, A. H.; Kim, A. C.; Marfatia, S. M.; Lutchman, M.; Hanspal, M.; Jindal, H.; Liu, S. C.; Low, P. S.; Rouleau, G. A.; Mohandas, N.; Chasis, J. A.; Conboy, J. G.; Gascard, P.; Takakuwa, Y.; Huang, S. C.; Benz, E. J. Jr.; Bretscher, A.; Fehon, R. G.; Gusella, J. F.; Ramesh, V.; Solomon, F.; Marchesi, V. T.; Tsukita, Shoichio; Tsukita, Sachiko; Arpin, M.; Louvard, D.; Tonks, N. K.; Anderson, J. M.; Fanning, A. S.; Bryant, P. J.; Woods, D. F.; Hoover, K. B. Trends Biochem. Sci. 23:281-82 (1998).
  231. Folate-mediated targeting of liposomal and viral vectors to cancer cells. Low, P. S.; Reddy, J. A. In: Gene Therapy & Molecular Biology from Basic Mechanisms to Clinical Applications. Gene Therapy Press.2:288-292 (1998).
  232. Indium-111-DTPA-Folate as a Potential Folate-Receptor-Targeted Radiopharmaceutical. Mathias, C. J.; Wang, S.; Waters, D. J.; Turek, J. J.; Low, P. S.; Green, M. A. J. Nuclear Medicine 39:1579-85 (1998).
  233. Purification of a glycoprotein elicitor of phytoalexin formation fromVerticillium Dahliae. Davis, D. A.; Low, P. S.; Heinstein, P. Physiological and Molecular Plant Pathology 52:259-73 (1998).
  234. The Effects of pH and Intraliposomal Buffer Strength on the Rate of Liposome Content Release and Intracellular Drug Delivery. Lee R. J.; Wang, S.; Turk, M. J.; Low, P. S. Bioscience Reports 18:69-78 (1998).
  235. Systemin Potentiates the Oxidative Burst in Cultured Tomato Cells. Stennis, M. J.; Chandra, S.; Ryan, C. A.; Low, P. S. Plant Physiol. 117:1031-6 (1998).
  236. Folate-Mediated Targeting of Antineoplastic Drugs, Imaging Agents, and Nucleic Acids to Cancer Cells. Wang, S.; Low, P. S. J. Controlled Release53:39-48 (1998).
  237. Effect of Band 3 Subunit Equilibrium on the Kinetics and Affinity of Ankyrin Binding to Erythrocyte Membrane Vesicles. Van Dort, H. M.; Moriyama, R.; Low, P. S. J. Biol. Chem. 273:14819-26 (1998).
  238. Biochemical Analysis of Potential Sites for Protein 4.1-Mediated Anchoring of the Spectrin-Actin Skeleton to the Erythrocyte Membrane. Workman, R. F.; Low, P. S. J. Biol. Chem. 273:6171-6 (1998).
  239. Effect of Purification Protocol on the Functional Properties of Erythrocyte Membrane Protein 4.1. Workman, R. F.; Low, P. S. Protein Expression and Purification 12:100-4 (1998).
  240. Folate-Targeted Liposomes for Drug Delivery. Lee, R. J.; Low, P. S. J. Liposome Research 7:455-66 (1997)
  241. Measurement of Ca2+ Fluxes During Elicitation of the Oxidative Burst in Aequorin-Transformed Tobacco Cells. Chandra, S.; Low, P. S. J. Biol. Chem.272:28274-80 (1997).
  242. Intracellular Delivery of Peptides and Proteins. Low, P. S.; Leamon, C. R. reprinted from ACS Professional Reference Book, Controlled Drug Delivery, Challenges and Strategies, published by the American Chemical Society, p. 11-25 (1997).
  243. Phospholipase D Involvement in the Plant Oxidative Burst. Taylor (Schroeder), A. T.; Low, P. S. Biochem. and Biophys. Res. Comm. 237:10-15 (1997).
  244. Design and Synthesis of 111In-DTPA-Folate for Use as a Tumor-Targeted Radiopharmaceutical. Wang, S.; Luo, J.; Lantrip, D. A.; Waters, D. J.; Mathias, C. J.; Green, M. A.; Fuchs, P. L.; Low, P. S. Bioconjugate Chemistry 8:673-9 (1997).
  245. Signal Transduction Pathways of the Plant Oxidative Burst. Low, P. S.; Schroeder, A. T. Plant-Microbe Interactions Vol. 3, chap. 2, p. 35-52. (1997).
  246. Erythrocyte Signal Transduction Pathways and their Possible Functions. Minetti, G.; Low, P. S. Current Opinion in Hematology 4:116-21 (1997).
  247. Identification of the Major Casein Kinase I Phosphorylation Sites on Erythrocyte Band 3. Wang, C. C.; Tao, M.; Wei, T.; Low, P. S. Blood 89:3019-24 (1997).
  248. Rapid Epitope Mapping. Low, P. S.; Yuan, J. Protein Protocols Handbook(ed. J. Walker) Humana Press, Inc., Totowa, N.J., p. 573-579 (1996).
  249. Riboflavin-enhanced Transport of Serum Albumin Across the Distal Pulmonary Epithelium. Wangensteen, O. D.; Bartlett, M. M.; James, J. K.; Yang, Z.-F.; Low, P. S. Pharmaceutical Research 13:1861-4 (1996).
  250. A Comparison of Methods for the Determination of the Oxidative Burst in Whole Plants. Schroeder, A. T.; Martin, G.; Low, P. S. Biology of Plant-Microbe Interactions, (eds. Stacey, G., Mullin, B. and Gresshoff, P.M.), International Society for Molecular Plant-Microbe Interactions, St. Paul, MN, 1996, pp. 15-20.
  251. The Pto Kinase Mediates a Signaling Pathway Leading to the Oxidative Burst in Tomato. Chandra, S.; Martin, G. B.; Low, P. S. Proc. Natl. Acad. Sci. USA 93:13393-97 1996).
  252. Peptide Mediated Release of Folate-Targeted Liposome Contents from Endosomal Compartments. Vogel, K.; Wang, S.; Lee, R. J.; Chmielewski, J.; Low, P. S. J. Am. Chem. Soc. 118:1581-86 (1996).
  253. Measurement of Endosome pH following Folate Receptor-mediated Endocytosis. Lee, R. J.; Wang, S.; Low, P. S. Biochim. Biophys. Acta 1312:237-42 (1996).
  254. Prostaglandin E2 Stimulates a Ca2+-dependent K+ Channel in Human Erythrocytes and Alters Cell Volume and Filterability. Li, Q.; Jungmann, V.; Kiyatkin, A.; Low, P. S. J. Biol. Chem. 271:18651-56 (1996).
  255. Tumor-Selective Radiopharmaceutical Targeting via Receptor-Mediated Endocytosis of Gallium-67-Deferoxamine-Folate. Mathias, C. J.; Wang, S.; Lee, R. J.; Waters, D. J.; Low, P. S.; Green, M. A. Journal of Nuclear Medicine37:1003-8 (1996).
  256. Rapid site-directed mutagenesis by a method that selects for full length mutated DNA. Wang, C. C.; Fernando, L. P.; Low, P. S. Nucleic Acids Research24:1378-79 (1996).
  257. The oxidative burst in plant defense: Function and signal transduction. Low, P. S.; Merida, J. R. Physiologia Plantarum 96:533-42 (1996).
  258. Activation of Phospholipase A by Plant Defense Elicitors. Chandra, S.; Heinstein, P. F.; Low, P. S. Plant Physiol. 110:979-86 (1996).
  259. Synthesis, Purification, and Tumor Cell Uptake of 67Ga-Deferoxamine-Folate, a Potential Radiopharmaceutical for Tumor Imaging. Wang, S.; Lee, R. J.; Mathias, C. J.; Green, M. A.; Low, P. S. Bioconjugate Chemistry 7:56-62 (1996).
  260. Plants and Human Neutrophil Oxidative Burst Complexes Contain Immunologically Related Proteins. Dwyer, S.; Legendre, L.; Heinstein, P. F.; Low, P. S.; Leto, T. L. Biochim. Biophys. Acta 1289:231-37 (1996).
  261. Methodologic considerations for the use of canine in vivo aged biotinylated erythrocytes to study RBC senescence. Christian, J. A.; Rebar, A. H.; Boon, G. D.; Low, P. S. Experimental Hematology 24:82-8 (1996).
  262. Evidence for a Mechanically Induced Oxidative Burst. Yahraus, T.; Chandra, S.; Legendre, L.; Low, P. S. Plant Physiol. 109:1259-66 (1995).
  263. The Design of pH-dependent Amphipathic Helices to Trigger Cytoplasmic Delivery of Liposome Encapsulated Molecules. Vogel, K. M.; Wang, S.; Low, P. S.; Chmielewski. J. A. Peptides: Chemistry, Structure and Biology (ed. Kanmaya, P.T.P.; Hodges, R. S.), ESCOM, Leiden, The Netherlands, 1995, pp. 371-372.
  264. Partial Characterization of the Cytoplasmic Domain of Human Kidney Band 3. Wang, C. C.; Moriyama, R.; Lombardo, C. R.; Low, P. S. J. Biol. Chem.270:17892-7 (1995).
  265. Crystallization and Preliminary X-ray Analysis of the Cytoplasmic Domain of Human Erythrocyte Band 3. Kiyatkin, A. B.; Munshi, S.; Johnson, J. E.; Low, P. S. PROTEINS: Structure, Function & Genetics 22:293-7 (1995).
  266. Vitamin-mediated delivery of proteins, antisense oligonucleotides and genes into living cells. Low, P. S. Restorative Neurology and Neuroscience 8:15 (1995).
  267. Role of Phosphorylation in the Elicitation of the Oxidative Burst in Cultured Soybean Cells. Chandra, S.; Low, P. S. Proc. Natl. Acad. Sci. USA 92:4120-3 (1995).
  268. Control of Erythrocyte Metabolism by Redox-Regulated Tyrosine Phosphatases and Kinases. Low, P. S.; Kiyatkin, A.; Li, Q.; Harrison, M. Protoplasma 184:196-202 (1995).
  269. Delivery of Antisense Oligodeoxyribonucleotides against the Human Epidermal Growth Factor Receptor into Cultured KB Cells using Folate-PEG-Liposomes. Wang, S.; Lee, R. J.; Gauchon, G.; Gorenstein, D. G.; Low, P. S. Proc. Natl. Acad. Sci. USA 92:3318-22 (1995).
  270. Folate-Mediated Tumor Cell Targeting of Liposome-Entrapped Doxorubicinin vitro. Lee, R. J.; Low, P. S. Biochim. Biophys. Acta 1233:134-44 (1995).
  271. Visualization of Elicitor Binding Loci at the Plant Cell Surface. Diekmann, W.; Herkt, B.; Low, P. S.; Nürnberger, T.; Scheel, D.; Terschüren, C.; Robinson, D. G. Planta 195:126-37 (1994).
  272. Calmodulin Modulates Protein 4.1 Binding to Human Erythrocyte Membranes. Lombardo, C. R.; Low, P. S. Biochim. Biophys. Acta 1196:139-44 (1994).
  273. Comparison of the Oxidative Burst Signaling Pathways of Plants and Human Neutrophils. Low, P. S.; Dwyer, S. C. Plant Responses to Environmental Stress, pp. 75-87 (1994).
  274. Endocytosis in Plants. Low, P. S.; Chanda, S. Annu. Rev. Plant Physiol. Plant Mol. Biol. 45:609-31 (1994).
  275. Selective Targeting of Malignant Cells with Cytotoxin-Folate Conjugates. Leamon, C. P.; Low, P. S. J. Drug Targeting 2:101-12 (1994).
  276. Phosphorylation of Human Erythrocyte Band 3 by Endogenous p72syk*. Harrison, M. L.; Isaacson, C. C.; Burg, D. L.; Geahlen, R. L.; Low, P. S. J. Biol. Chem. 269:955-9 (1994).
  277. Delivery of Liposomes into Cultured KB Cells Via Folate Receptor-Mediated Endocytosis. Lee, R. J.; Low, P. S. J. Biol. Chem. 269:3198-204 (1994).
  278. Calorimetric Evidence for Allosteric Subunit Interactions Associated with Inhibitor Binding to Band 3 Transporters. Van Dort, H. M.; Low, P. S.; Cordes, K. A.; Scopfer, L. M.; Salhany, J. M. J. Biol. Chem. 269:59-61 (1994).
  279. Non-random Association of Free Iron with Membranes of Sickle and b-thalassemic Erythrocytes. Repka, T.; Shalev, O.; Reddy, R.; Yuan, J.; Rachmilewitz, E. A.; Low, P. S.; Hebbel, R. P. Blood 82:3204-10 (1993).
  280. Senescence of Canine Biotinylated Erythrocytes: Increased Autologous Immunoglobulin Binding Occurs on Erythrocytes Aged In Vivo for 104 to 110 Days. Christian, J. A.; Rebar, A. H.; Boon, G. D.; Low, P. S. Blood 82:3469-73 (1993).
  281. Phospholipase C Activation During Elicitation of the Oxidative Burst in Cultured Plant Cells. Legendre, L.; Yueh, Y. G.; Crain, R.; Haddock, N.; Heinstein, P. F.; Low, P. S. J. Biol. Chem. 268:24559-63 (1993).
  282. Cytotoxicity of Folate-Pseudomonas Exotoxin Conjugates Towards Tumor Cells: Contribution of Translocation Domain. Leamon, C. P.; Pastan, I.; Low, P. S. J. Biol. Chem. 268:24847-54 (1993).
  283. Endocytosis of Folate-protein Conjugates: Ultrastructural Localization in KB Cells. Turek, J. J.; Leamon, C. P.; Low, P. S. J. Cell Sci. 106:423-30 (1993).
  284. Regulation of Glycolysis Via Reversible Enzyme Binding to the Membrane Protein, Band 3. Low, P. S.; Rathinavelu, R.; Harrison, M. J. Biol. Chem.268:14627-31 (1993).
  285. Regulation of Linkages Between the Erythrocyte Membrane and its Skeleton by 2,3-diphosphoglycerate. Moriyama, R.; Lombardo, C. R.; Workman, R. F.; Low, P. S. J. Biol. Chem. 268:10990-6 (1993).
  286. Independent Elicitation of the Oxidative Burst and Phytoalexin Formation in Cultured Plant Cells. Davis, D.; Merida, J.; Legendre, L.; Low, P. S.; Heinstein, P. F. Phytochemistry 32:607-11 (1993).
  287. Membrane Folate Binding Proteins are Responsible for the Folate-Protein Conjugate Endocytosis into Cultured Cells. Leamon, C. P.; Low, P. S. Biochem. J. 291:855-60 (1993).
  288. Characterization of the Oligogalacturonide-Induced Oxidative Burst in Cultured Soybean Cells. Legendre, L.; Rueter, S.; Heinstein, P.; Low, P. S. Plant Physiol. 102:233-40 (1993).
  289. Characterization of the Autologous Antibodies that Opsonize Erythrocytes with Clustered Integral Membrane Proteins. Turrini, F.; Mannu, F.; Arese, P.; Yuan, J.; Low, P. S. Blood 81:3146-52 (1993).
  290. Comparison of Elicitor and Vitamin Receptor-Mediated Endocytosis in Cultured Soybean Cells. Low, P. S.; Legendre, L.; Heinstein, P. F.; Horn, M. A. J. Exp. Botany 44:269-74 (1993).
  291. The Effect of Mild Oxidants on Glycolysis in Human Erythrocytes. Harrison, M. L.; Rathinavelu, P.; Arese, P.; Geahlen, R. L.; Low, P. S. BioChem J.283:622-3 Part 2 (1992).
  292. Structural and Functional Characterization of Band 3 from Southeast Asian Ovalocytes. Moriyama, R.; Ideguchi, H.; Lombardo, C. R.; Van Dort, H. M.; Low, P. S. J. Biol. Chem. 267:25792-7 (1992).
  293. Cytotoxicity of Momordin-Folate Conjugates in Cultured Human Cells. Leamon, C. P.; Low, P. S. J. Biol. Chem. 267:24966-71 (1992).
  294. Induction of Secondary Metabolite-Phytoalexin Formation in Plant Cell Suspension Cultures. Heinstein, P.; Horn, M.; Davis, D.; Low, P. S. Secondary Metal Biosynthesis & Metabolism (eds. R.J. Ptroski & S.P. McCormick) NY, p. 189-195 (1992).
  295. An Efficient Method for Conjugation of Thiamine to Proteins. Jayamani M. and Low P.S., Bioorganic and Med. Chem. Lett. 2:1007-12 (1992).
  296. Evidence for Participation of GTP-binding Proteins in Elicitation of the Rapid Oxidative Burst in Cultured Soybean Cells. Legendre, L.; Heinstein, P. F.; Low, P. S. J. Biol. Chem. 267:20140-7 (1992).
  297. Band 3: Calorimetry, Cytoskeletal Associations, Role in Metabolic Regulation, and Role in Aging. Low, P. S. Progress in Cell Research, (eds. E. Bamberg and H. Passow) Elsevier Science Publishers B.V., Amsterdam, Vol. 2, chap. 21, pp. 219-225 (1992).
  298. Expression, Purification and Characterization of Functional Dimeric Cytoplasmic Domain of Human Erythrocyte Band 3 in E. coli. Wang, C. C.; Badylak, J. A.; Lux, S. E.; Moriyama, R.; Dixon, J. E.; Low, P. S. Protein Science1:1206-14 (1992).
  299. Resealing of Protein Tyrosine Kinase Substrates Into Human Erythrocytes by Rapid Freezing and Thawing in Liquid Nitrogen. Harrison, M.; Isaacson, C.; Rathinavelu, P.; Low, P. S. The Use of Resealed Erythrocytes as Carriers and Bioreactors, (eds. M. Magnani and J.R. DeLoach), Plenum Publ. Co.: New York, pp 111-118 (1992).
  300. Enhancement of Phytoalexin Accumulation in Cultured Plant Cells by Oxalate. Davis, D. A.; Tsao, D.; Seo, J.-H.; Emery, A.; Low, P. S.; Heinstein, P. Phytochem. 31:1603-7 (1992).
  301. Epitope Mapping by a Method that Requires No Amino Acid Sequence Information. Yuan, J.; Low, P. S. Anal. Biochem. 205:179-82 (1992).
  302. Localization of the Protein 4.1 Binding Site on the Cytoplasmic Domain of Erythrocyte Membrane Band 3. Lombardo, C. R.; Willardson, B. M.; Low, P. S. J. Biol. Chem. 267:9540-6 (1992).
  303. Isolation, Characterization and Immunoprecipitation Studies of Immune Complexes from Membranes of b-Thalassemic Erythrocytes. Yuan, J.; Kannan, R.; Shinar, E.; Rachmilewitz, E. A.; Low, P. S. Blood 79:3007-13 (1992).
  304. Characterization of Parameters Influencing Receptor-Mediated Endocytosis in Cultured Soybean Cells. Horn, M. A.; Heinstein, P. F.; Low, P. S. Plant Physiol. 98:673-9 (1992).
  305. Effect of Elicitation and Changes in Extracellular pH on the Cytoplasmic and Vacuolar pH of Suspension Cultured Soybean Cells. Horn, M.; Meadows, R.; Apostol, I.; Jones, C. R.; Gorenstein, D. G.; Heinstein, P. F.; Low, P. S. Plant Physiol. 98:680-6 (1992).
  306. Clustering of Integral Membrane Proteins of the Human Erythrocyte Membrane Stimulates Autologous IgG Binding, Complement Deposition and Phagocytosis. Turrini, F.; Arese, P.; Yuan, J.; Low, P. S. J. Biol. Chem.266:23611-17 (1991).
  307. Isolation and Partial Characterization of Antibody- and Globin-Enriched Complexes from Membranes of Dense Human Erythrocytes. Kannan, R.; Yuan, J.; Low, P. S. Biochem. J. 278:57-62 (1991).
  308. Role of Hemoglobin Denaturation and Band 3 Clustering in Initiating Red Cell Removal. Low, P. S. “Red Cell Aging” (ed. M. Magnani), Plenum Press: New York, Adv. Exp. Med. Biol. 307:173-183 (1991).
  309. Delivery of Macromolecules into Living Cells: A Method that Exploits Folate Receptor Endocytosis. Leamon, C. P.; Low, P. S. Proc. Natl. Acad. Sci. USA88:5572-76 (1991).
  310. Immobilized Artificial Membrane Chromatography. Chae, W.-G.; Luo, C.; Rhee, D. M.; Lombardo, C. R.; Low, P. S.; Pidgeon, C. Modern Phytochemical Methods (eds. N.H. Fischer et al.) Plenum Press: NY, Chap. 5, pp. 149-174 (1991).
  311. Membrane Protein Crystallization: Observations and Use of Short Chain Phospholipids as Amphiphiles. Eisele, J.-L.; Keller, T.; K`nig, N.; Stauffer, N.; Rosenbusch, J. P.; Low, P. S. Journal of Crystal Growth 110:96-102 (1991).
  312. Contribution of the Band 3-Ankyrin Interaction to Erythrocyte Membrane Mechanical Stability. Low, P. S.; Willardson, B. M.; Mohandas, N.; Rossi, M.; Shohet, S. Blood 77:1581-6 (1991).
  313. Role of Band 3 Tyrosine Phosphorylation in Regulation of Erythrocyte Glycolysis. Harrison, M. L.; Rathinavelu, P.; Arese, P.; Geahlen, R. L.; Low, P. S.; J. Biol. Chem. 266:4106-11 (1991).
  314. Biotin-Mediated Delivery of Exogeneous Macromolecules into Soybean Cells. Horn, M. A.; Heinstein, P. F.; Low, P. S. Plant Physiol. 93:1492-6 (1990).
  315. Kinetics and Regulation of the Ankyrin-Band 3 Interaction of the Human Red Blood Cell Membrane. Thevenin, B. J.-M.; Low, P. S. J. Biol. Chem.265:16166-72 (1990).
  316. Extracellular Control of Erythrocyte Metabolism Mediated by a Cytoplasmic Tyrosine Kinase. Low, P. S.; Geahlen, R. L.; Mehler, E.; Harrison, M. L. Biomed. Biochim. Acta 49:135-40 (1990).
  317. Secondary Product Formation and Transmembrane Signaling in Plant Cells. Apostol, I.; Horn, M.; Davis, D.; Low, P. S.; Heinstein, P. Highlights of Modern Biochemistry (eds. A. Kotyk, J. Skoda, V. Paces and V. Kostka) VSP International Science Publishers, Zeist 1989, pp. 463-73, (1990).
  318. The Other Functions of Erythrocyte Membrane Band 3. Low, P. S.; Willardson, B. M.; Thevenin, B.; Kannan, R.; Mehler, E.; Geahlen, R. L.; Harrison, M. L. Anion Transport Protein of the Red Blood Cell Membrane, (eds. N. Hamasaki and M.L. Jennings), Springer Verlag, pp. 103-18 (1989).
  319. Receptor-Mediated Endocytosis in Plant Cells. Horn, M.; Heinstein, P. F.; Low, P. S. The Plant Cell 1:1003-9 (1989).
  320. Effect of Hemoglobin Denaturation on Membrane Structure and IgG Binding: Role in Red Cell Aging. Low, P. S.; Kannan, R. The Red Cell: Seventh Ann Arbor Conference (ed. G. Brewer,) A.R. Liss: New York, pp. 525-52 (1989).
  321. Effect of Age of Cell Suspension Cultures on Susceptibility to a Fungal Elicitor. Apostol, I.; Low, P. S.; Heinstein, P. Plant Cell Reports 7:692-95 (1989).
  322. Identification and Partial Characterization of the Denaturation Transition of the Light Harvesting Complex II of Spinach Chloroplast Membranes. Smith, K. A.; Ardelt, B. K.; Huner, N. P. A.; Krol, M.; Myscich, E.; Low, P. S. Plant Physiol.90:492-9 (1989).
  323. Identification and Partial Characterization of the Denaturation Transition of the Photosystem II Reaction Center of Spinach Chloroplast Membranes. Smith, K. A.; Low, P. S. Plant Physiol. 90:575-81 (1989).
  324. Localization of the Ankyrin Binding Site on Erythrocyte Membrane Protein, Band 3. Willardson, B. M.; Thevenin, B. J.-M.; Harrison, M. L.; Kuster, W. M.; Benson, M. D.; Low, P. S. J. Biol. Chem. 264:15893-9 (1989).
  325. The Redox State of Cysteines 201 and 317 of the Erythrocyte Anion Exchanger Is Critical for Ankyrin Binding. Thevenin, B. J.-M.; Willardson, B. M.; Low, P. S. J. Biol. Chem. 264:15886-92 (1989).
  326. Fatty Acid Composition of Lipids Which Copurify with Band 3. Maneri, L. R.; Low, P. S. Biochem. Biophys. Res. Comm. 159:1012-19 (1989).
  327. Rapid Stimulation of an Oxidative Burst During Elicitation of Cultured Plant Cells: Role in Defense and Signal Transduction. Apostol, I.; Heinstein, P.; Low, P. S. Plant Physiol. 90:109-16 (1989).
  328. Interaction of Native and Denatured Hemoglobins with Band 3: Consequences for Erythrocyte Structure and Function. Low, P. S. Red Blood Cell Membranes, (eds. P. Agre and P. Parker) Marcel Dekker, Inc., New York, pp. 237-260 (1989).
  329. Elicitor-Induced pH Changes in Cultured Soybean Cells. Apostol, I.; Low; P. S.; Heinstein, P. F. J. Cell. Biochem. 12C:260 (1988).
  330. Structural Stability of the Erythrocyte Anion Transporter, Band 3, in Different Lipid Environments: a Differential Scanning Calorimetric Study. Maneri, L. R.; Low, P. S. J. Biol. Chem. 263:16170-8 (1988).
  331. Isolation and Characterization of the Hemichrome-Stabilized Membrane Protein Aggregates from Sickle Erythrocytes: Major Site of Autologous Antibody Binding. Kannan, R.; Labotka, R.; Low, P. S. J. Biol. Chem. 263:13766-73 (1988).
  332. Immunocytochemical Localization of Band 3 Protein in the Rat Collecting Duct. Verlander, J. W.; Madsen, K. M.; Low, P. S.; Allen, D. P.; Tisher, C. C. Amer. J. Physiol. 255:F115-25 (1988).
  333. Interaction of Amphiphiles with Integral Membrane Proteins: Structural Destabilization of the Anion Transport Protein of the Erythrocyte Membrane by Fatty Acids, Fatty Alcohols, and Fatty Amines. Gruber, H. J.; Low, P. S. Biochim. Biophys. Acta. 944:414-24 (1988).
  334. In Vivo Low Temperature-Induced Decrease in 3-Transhexadecenoic Acid Influences Oligomerization of LHCII. Williams, J. P.; Huner, N. P. A.; Krol, M.; Maissan, E.; Low, P. S.; Roberts, D.; Thompson, J. E. Proc. VIIth Int. Congress Photosynth.(1987).
  335. Band 3 and Ankyrin Homologues Are Present in Eye Lens: Evidence for All Major Erythrocyte Membrane Components in Same Non-Erythroid Cell. Allen, D. P.; Low, P. S.; Dola, A.; Maisel, H. Biochemical and Biophysical Research Communications 149:266-75 (1987).
  336. Low Temperature Development Induces a Specific Decrease in trans-Î3-Hexadecenoic Acid Content which Influences LHCII Organization. Huner, N. P. A.; Krol, M.; Willians, J. P.; Maissan, E.; Low, P. S.; Roberts, D.; Thompson, J. E. Plant Physiol. 84:12-18 (1987).
  337. Inhibition of Elicitor-Induced Phytoalexin Formation in Cotton and Soybean Cells by Citrate. Apostol, I.; Low, P. S.; Heinstein, P.; Stipanovic, R. D.; Altman, D. W. Plant. Physiol. 84:1276-80 (1987).
  338. Tyrosine Phosphorylation of Band 3 Inhibits Peripheral Protein Binding. Low, P. S.; Allen, D. P.; Zioncheck, T. F.; Chari, P.; Willardson, B. M.; Geahlen, R. L.; Harrison, M. L. J. Biol. Chem. 262:4592-6 (1987).
  339. Partial Characterization of the Copolymerization Reaction of Erythrocyte Membrane Band 3 with Hemichromes. Waugh, S. M.; Walder, J. A.; Low, P. S. Biochemistry 26:1777-83 (1987).
  340. Signal Transduction Across Plasma Membranes of Cultured Cells. Low, P. S.; Heinstein, P. F. J. Cell. Biochem. 10B:29 (1986).
  341. Structure and Function of the Cytoplasmic Domain of Band 3: Center of Erythrocyte Membrane-Peripheral Protein Interactions. Low, P. S. Biochem. Biophys. Acta 864:145-67 (1986).
  342. Identification of the Soluble Coupling Factor Transition in Calorimetric Scans of Chloroplast Membranes. Smith, K. A.; Ardelt, B. K.; Low, P. S. Biochemistry 25:7099-105 (1986).
  343. Heinz Bodies Induce Clustering of Band 3, Glycophorin and Ankyrin in Sickle Cell Erythrocytes. Waugh, S. M.; Willardson, B. M.; Kannan, R.; Lobotka, R. J.; Low, P. S. J. Clin. Invest. 78:1155-60 (1986).
  344. Elicitor Stimulation of the Defense Response in Cultured Plant Cells Monitored by Fluorescent Dyes. Low, P. S.; Heinstein, P. F. Arch. Biochem. Biophys. 249:472-9 (1986).
  345. The Redox Centers of Xanthine Oxidase are on Independent Structural Domains of the Enzyme. Nichols, M. B.; Low, P. S. Arch. Biochem. Biophys.250:488-97 (1986).
  346. Detection of Protein Kinase Activity in Sodium Dodecyl Sulfate - Polyacrylamide Gels. Geahlen, R. L.; Anostario, M. Jr.; Low, P. S.; Harrison, M. Anal. Biochem. 153:151-8 (1986).
  347. Possible Mechanism of Regulation of Membrane-cytoskeletal Interactions in Erythrocytes. Low, P. S.; Appell, K. C. Contractile Proteins in Muscle and Non-Muscle Cells, (eds. E.E. Alia, N. Arena, and M.A. Russo), Praeger Scientific: New York. pp. 383-392, (1985).
  348. Identification and Partial Characterization of Xanthine Oxidase Transitions of the Milk Fat Globule Membrane. Burnier, R. C.; Low, P. S. Arch. Biochem. Biophys. 240:60-9 (1985).
  349. Molecular Basis of the Biological Compatibility of Nature's Osmalytes, Low, P. S. Transport Processes, Iono- and Osmoregulation (eds. R. Giles and M. Gilles-Baillien) Springer-Verlag: Berlin, pp.469-77 (1985).
  350. The Role of Hemoglobin Denaturation and Band 3 Clustering in Red Blood Cell Aging. Low, P. S.; Waugh, S. M.; Zinke, K.; Drenckhahn, D. Science227:531-3 (1985).
  351. Turnip Yellow Mosaic Virus and its Empty Capsid Have Thermal Stabilities with Opposite pH Dependence: Differential Scanning Calorimetry and 31P NMR Studies. Viruclachalem, R.; Low, P. S.; Argos, P.; Markley, J. L. Virology146:213-20 (1985).
  352. Hemichrome Binding to Band 3: Nucleation of Heinz Bodies on the Erythrocyte Membrane. Waugh, S. M.; Low, P. S. Biochemistry 24:34-9 (1985).
  353. Characterization of Reversible Conformational Equilibrium of the Cytoplasmic Domain of Erythrocyte Membrane Band 3. Low, P. S.; Westfall, M. A.; Allen, D. P.; Appell, K. C. J. Biol. Chem. 259:13070-6 (1984).
  354. The Interaction of Hemoglobin with the Cytoplasmic Domain of Band 3 of the Human Erythrocyte Membrane. Walder, J. A.; Chatterjee, R.; Steck, T. L.; Low, P. S.; Musso, G. F.; Kaiser, E. T.; Rogers, P. H.; Arnone, A. J. Biol. Chem.259:10238-46 (1984).
  355. T and B Lymphocytes Express Distinct Tyrosine Protein Kinases. Harrison, M.; Low, P. S.; Geahlen, R. T. J. Biol. Chem. 259:9348-50 (1984).
  356. Possible Mechanism of Regulation of Membrane-Cytoskeletal Interactions in Erythrocytes, in Contractile Proteins in Muscle and Non-muscle Cell System. Low, P. S.; Appell, K. C. in press (1984).
  357. Identification of Immunoreactive Forms of Human Erythrocyte Band 3 in Nonerythroid Cells. Drenckhahn, D.; Zinke, K.; Schaver, U.; Appell, K. C.; Low, P. S. Eur. J. Cell Biol. 34:144-50 (1984).
  358. Distinct Tyrosine Protein Kinases are Expressed by T and B Lymphocytes. Harrison, M. L.; Low, P. S.; Geahlen, R. L. Fed. Proc. 43:1468 (1984).
  359. Search for an Endotherm in Chloroplast Lamellar Membranes Associated with Chilling-Inhibition of Photosynthesis. Low, P. S.; Cramer, W. A.; Ort, D.; Whitmarsh, J. Arch. Biochem. Biophys. 231:336-44 (1984).
  360. Differential Scanning Calorimetry of Milk Fat Globule Membranes. Burnier, R. C.; Low, P. S. Fed. Proc. 42:1773 (1983).
  361. Differential Scanning Calorimetry of Milk Fat Globule Membranes. Appell, K. C.; Low, P. S. Biochim. Biophys. Acta. 690:243-50 (1982).
  362. Anesthetic-Ion Channel Interactions: The Effect of Lidocaine on the Stability and Transport Properties of the Membrane-Spanning Domain of Band 3. Davio, S. R.; Low, P. S. Arch. Biochem. Biophys. 218:421-8 (1982).
  363. Characterization of the Calorimetric C Transition of the Human Erythrocyte Membrane. Davio, S. R.; Low, P. S. Biochemistry 21:3585-93 (1982).
  364. Evidence for Restricted Oligosaccharide Mobility at the Erythrocyte Membrane Surface: A Fluorescence Study. Low, P. S.; Cramer, W. A.; Abraham, G.; Bone, R.; Ferguson-Seagall, M. Arch. Biochem. Biophys. 214:675-80 (1982).
  365. Evaluation of the Structural Interdependence of the Membrane-Spanning and Cytoplasmic Domains of Band 3. Appell, K. C.; Low, P. S. Biochemistry21:2151-7, (1982).
  366. Partial Structural Characterization of the Cytoplasmic Domain of the Erythrocyte Membrane Protein, Band 3. Appell, K. C.; Low, P. S. J. Biol. Chem.256:11104-11 (1981).
  367. In vitro Promotion by Auxins of Divalent Ion Release From Soybean Membranes. Buckhout, T. J.; Young, K. A.; Low, P. S.; Morre, D. J. J. Plant Physiol. 68:512-5 (1981).
  368. Effect of pH on the Cytoplasmic Domain of the Human Erythrocyte Membrane Protein, Band 3. Low, P. S.; Appell, K. C. Fed. Proc. 40:1192 (1981).
  369. Lateral Diffusion of Glycophorin Reconstituted into Phospholipid Multibilayers. Wu, E. S.; Low, P. S.; Webb, W. W. Biophys. J. 33:109a (1981).
  370. The Effect of Anesthetic Charge on Anesthetic-Phospholipid Interactions. Davio, S. R.; Low, P. S. Biochim. Biophys. Acta 644:157-64, (1981).
  371. Differential Scanning Calorimetry of Chloroplast Membranes: Identification of an Endothermic Transition Associated with the Water-Splitting Complex of Photosystem II. Cramer, W. A.; Whitmarsh, J.; Low, P. S. Biochemistry20:157-62 (1981).
  372. Differential Scanning Calorimetry of Chloroplast Membranes. Cramer, W. A.; Low, P. S.; Selman, B. R.; Whitmarsh, J.; Widger, W. Proc. 5th Int. Conf. Photosynth., (ed. G. Akoyunoglou), pp. 121-129(1981).
  373. Differential Scanning Calorimetry of Chloroplast Membranes: Identification and Partial Characterization of the A Transition. Whitmarsh, C. J.; Cramer, W. A.; Low, P. S. Fed. Proc. 39:1023 (1980).
  374. Response of Isolated Plant Membranes to Auxins: Calcium Release. Buckhout, T. J.; Young, K. A.; Morre', D. J.; Low, P. S. Botanical Gaz. 141:418-21 (1980).
  375. Colvalent Labeling of Specific Membrane Carbohydrate Residues with Fluorescent Probes. Abraham, G.; Low, P. S. Biochem. Biophys. Acta 597:285-91 (1980).
  376. Calcium Displacement by Local Anestetics: Dependence on pH and Anesthetic Charge. Low, P. S.; Lloyd, D. H.; Stein, T. M.; Rogers, J. A. III. J. Biol. Chem. 254:4119-25 (1979).
  377. Specific Fluorescence Labeling of Erythrocyte Membrane Proteins. Abraham, G.; Low, P. S. Fed. Proc. 38:357 (1979).
  378. Calcium Modification of the Anion Transport Mechanism in Red Blood Cells. Gunn, R. B.; Frohlich, O.; Macintrye, J. D.; Low, P. S. Biophys. J. 25:106a (1979).
  379. The Effects of Anion Transport Inhibitors on Structural Transitions in Erythrocyte Membranes. Snow, J. W.; Brandts, J. F.; Low, P. S. Biochem. Biophys. Acta 512:579-91 (1978).
  380. Protein Hydration Changes During Catalysis: An Important Contribution to the Properties of Enzyme Catalyzed Reactions. Low, P. S. Symp. Biol. Hungarica 21:217-47 (1978).
  381. Specific Cation Modulation of Anion Transport Across the Human Erythrocyte Membrane. Low, P. S. Biochem. Biophys. Acta 514:264-73 (1978).
  382. Calcium-Anesthetic Interactions in the Erythrocyte Membrane. Low, P. S.; Roger, J. A. III. J. Supramol. Structures, Suppl. 2:211 (1978).
  383. The Interaction of Adenine Nucleotides with the Red Cell Membrane: A Calorimetric Study. Low, P. S.; Brandts, J. F. Arch. Biochem. Biophys.190:640-6 (1978).
  384. Protein Water Binding Ability Correlates with Cellular Osmolarity. Low, P. S.; Hoffman, K.; Swezey, R.; Somero, G. N. Experientia 34:314-5 (1978).
  385. Enzyme Hydration May Explain Catalytic Efficiency Differences Among Lactate Dehydrogenase Homologues. Somero, G. N.; Low, P. S. Nature266:276-8 (1977).
  386. Neutral Salt Effects on the Velocity and Activation Volume of the Lactate Dehydrogenase Reaction: Evidence for Enzyme Hydration Changes During Catalysis. Somero, G. N.; Newbauer, M.; Low, P. S. Arch. Biochem. 181:438-46 (1977).
  387. Identification of a Structural Region Involved in Anion Transport. Snow, J. W.; Brandts, J. F.; Low, P. S. Fed. Proc. 36:896 (l977).
  388. Eurytolerant Proteins: Mechanisms for Extending the Environmental Tolerance Range of Enzyme-Ligand Interactions. Somero, G. N.; Low, P. S. American Naturalist 111:527-38 (1977).
  389. Adaptation of Muscle Pyruvate Kinases to Environmental Temperatures and Pressures. Low, P. S.; Somero, G. N. J. Exp. Zool. 198:1-12 (1976).
  390. Temperature: A "Shaping Force" in Enzyme Evolution. Somero, G. N.; Low, P. S. Biochemical Society Symposium 41:33-42 (1976).
  391. Pressure Effects on Enzyme Structure and Function in vitro and in vivo. Low, P. S.; Somero, G. N. Comp. Biochem. Physiol. 52B:67-74 (l975).
  392. Protein Hydration Changes During Catalysis: A New Mechanism to Account for Enzymic Rate-Enhancement and Ion Activation/Inhibition of Enzymes. Low, P. S.; Somero, G. N. Proc. Natl. Acad. Sci. USA 72:3305-9 (1975).
  393. Activation Volumes in Enzymic Catalysis: Their Sources and Modification by Low Molecular Weight Solutes. Low, P. S.; Somero, G. N. Proc. Natl. Acad. Sci. USA 72:3014-18 (1975).
  394. Temperature Adaptation of Enzymes: A Proposed Molecular Basis for the Different Catalytic Efficiencies of Enzymes from Ectotherms and Endotherms. Low, P. S.; Somero, G. N. Comp. Biochem. Physiol. 49B:307-12 (1974).
  395. Bile Pigments in the Blood Serum of Fish from the Family Cottidae. Low, P. S.; Bada, J. L. Comp. Biochem. Physiol. 47A:411-18 (1974).
  396. Temperature Adaptation of Enzymes: Roles of the Free Energy, the Enthalpy, and the Entropy of Activation. Low, P. S.; Bada, J. L.; Somero, G. N.Proc. Nat. Acad. Sci. 70:430-2 (1973).